Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Frederik Barkhof

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Concepts & Ideas

Disorders

Anatomy

Physiology

Disease Progression

Procedures

Activities & Behaviors

Computer-Assisted Image Processing

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Zarei Mojtaba; Patenaude Brian; Damoiseaux Jessica; Morgese Ciro; Smith Steve; Matthews Paul M; Barkhof Frederik; Rombouts Serge; Sanz-Arigita Ernesto; Jenkinson Mark
Combining shape and connectivity analysis: an MRI study of thalamic degeneration in Alzheimer's disease.
Moraal Bastiaan; Pohl Christoph; Uitdehaag Bernard M J; Polman Chris H; Edan Gilles; Freedman Mark S; Hartung Hans-Peter; Kappos Ludwig; Miller David H; Montalban Xavier; Lanius Vivian; Sandbrink Rupert; Barkhof Frederik
Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study.
Goos Jeroen D C; Kester M I; Barkhof Frederik; Klein Martin; Blankenstein Marinus A; Scheltens Philip; van der Flier Wiesje M
Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Frederik Barkhof (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Zarei Mojtaba; Patenaude Brian; Damoiseaux Jessica; Morgese Ciro; Smith Steve; Matthews Paul M; Barkhof Frederik; Rombouts Serge; Sanz-Arigita Ernesto; Jenkinson Mark
Combining shape and connectivity analysis: an MRI study of thalamic degeneration in Alzheimer's disease.
NeuroImage 2010;49(1):1-8.
2009: Moraal Bastiaan; Pohl Christoph; Uitdehaag Bernard M J; Polman Chris H; Edan Gilles; Freedman Mark S; Hartung Hans-Peter; Kappos Ludwig; Miller David H; Montalban Xavier; Lanius Vivian; Sandbrink Rupert; Barkhof Frederik
Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study.
Archives of neurology 2009;66(11):1345-52.
2009: Goos Jeroen D C; Kester M I; Barkhof Frederik; Klein Martin; Blankenstein Marinus A; Scheltens Philip; van der Flier Wiesje M
Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition.
Stroke; a journal of cerebral circulation 2009;40(11):3455-60.
2009: Kappos Ludwig; Freedman Mark S; Polman Chris H; Edan Gilles; Hartung Hans-Peter; Miller David H; Montalbán Xavier; Barkhof Frederik; Radü Ernst-Wilhelm; Metzig Carola; Bauer Lars; Lanius Vivian; Sandbrink Rupert; Pohl Christoph;
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.
Lancet neurology 2009;8(11):987-97.
2009: Wattjes Mike P; Henneman Wouter J P; van der Flier Wiesje M; de Vries Oscar; Träber Frank; Geurts Jeroen J G; Scheltens Philip; Vrenken Hugo; Barkhof Frederik
Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT.
Radiology 2009;253(1):174-83.
2009: van de Pol L A; Verhey F; Frisoni G B; Tsolaki M; Papapostolou P; Nobili F; Wahlund L-O; Minthon L; Frölich L; Hampel H; Soininen H; Knol D L; Barkhof F; Scheltens P; Visser P J
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study.
Journal of neurology, neurosurgery, and psychiatry 2009;80(10):1069-74.
2009: van der Voorn J Patrick; Pouwels Petra J W; Salomons Gajja S; Barkhof Frederik; van der Knaap Marjo S
Unraveling pathology in juvenile Alexander disease: serial quantitative MR imaging and spectroscopy of white matter.
Neuroradiology 2009;51(10):669-75.
2009: Henneman W J P; Vrenken H; Barnes J; Sluimer I C; Verwey N A; Blankenstein M A; Klein M; Fox N C; Scheltens P; Barkhof F; van der Flier W M
Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease.
Neurology 2009;73(12):935-40.
2009: Korteweg T; Tintore M; Uitdehaag B M J; Knol D L; Vrenken H; Rovira A; Frederiksen J; Miller D H; Fernando K; Filippi M; Agosta F; Rocca M A; Fazekas F; Enzinger C; Parry A; Polman C H; Montalban X; Barkhof F
A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome.
European radiology 2009;19(9):2244-8.
2009: Rocca Maria A; Absinta Martina; Valsasina Paola; Ciccarelli Olga; Marino Silvia; Rovira Alex; Gass Achim; Wegner Christiane; Enzinger Christian; Korteweg Tjimen; Sormani Maria Pia; Mancini Laura; Thompson Alan J; De Stefano Nicola; Montalban Xavier; Hirsch Jochen; Kappos Ludwig; Ropele Stephan; Palace Jacqueline; Barkhof Frederik; Matthews Paul M; Filippi Massimo
Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study.
Human brain mapping 2009;30(8):2412-25.
2009: Roosendaal S D; Moraal B; Pouwels P J W; Vrenken H; Castelijns J A; Barkhof F; Geurts J J G
Accumulation of cortical lesions in MS: relation with cognitive impairment.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(6):708-14.
2009: Seewann A; Kooi E-J; Roosendaal S D; Barkhof F; van der Valk P; Geurts J J G
Translating pathology in multiple sclerosis: the combination of postmortem imaging, histopathology and clinical findings.
Acta neurologica Scandinavica 2009;119(6):349-55.
2009: Barkhof Frederik; Calabresi Peter A; Miller David H; Reingold Stephen C
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials.
Nature reviews. Neurology 2009;5(5):256-66.
2009: Rovaris M; Barkhof F; Calabrese M; De Stefano N; Fazekas F; Miller D H; Montalban X; Polman C; Rocca M A; Thompson A J; Yousry T A; Filippi M
MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.
Neurology 2009;72(19):1693-701.
2009: Seewann Alexandra; Vrenken Hugo; van der Valk Paul; Blezer Erwin L A; Knol Dirk L; Castelijns Jonas A; Polman C H; Pouwels Petra J W; Barkhof Frederik; Geurts Jeroen J G
Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
Archives of neurology 2009;66(5):601-9.
2009: Minneboo A; Uitdehaag B M J; Jongen P; Vrenken H; Knol D l; van Walderveen M A A; Polman C H; Castelijns J A; Barkhof F
Association between MRI parameters and the MS severity scale: a 12 year follow-up study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(5):632-7.
2009: Chan Dennis; Anderson Valerie; Pijnenburg Yolande; Whitwell Jennifer; Barnes Jo; Scahill Rachael; Stevens John M; Barkhof Frederik; Scheltens Philip; Rossor Martin N; Fox Nick C
The clinical profile of right temporal lobe atrophy.
Brain : a journal of neurology 2009;132(Pt 5):1287-98.
2009: Wattjes Mike P; Barkhof Frederik
High field MRI in the diagnosis of multiple sclerosis: high field-high yield?
Neuroradiology 2009;51(5):279-92.
2009: Barkhof Frederik; Filippi Massimo
MRI--the perfect surrogate marker for multiple sclerosis?
Nature reviews. Neurology 2009;5(4):182-3.
2009: Vellinga Machteld M; Vrenken Hugo; Hulst Hanneke E; Polman Chris H; Uitdehaag Bernard M J; Pouwels Petra J W; Barkhof Frederik; Geurts Jeroen J G
Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients: an exploratory study.
Journal of magnetic resonance imaging : JMRI 2009;29(4):774-9.
2009: Staekenborg Salka S; Koedam Esther L G E; Henneman Wouter J P; Stokman Pauline; Barkhof Frederik; Scheltens Philip; van der Flier Wiesje M
Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy.
Stroke; a journal of cerebral circulation 2009;40(4):1269-74.
2009: Korteweg T; Rovaris M; Neacsu V; Filippi M; Comi G; Uitdehaag B M; Knol D L; Polman C H; Barkhof F; Vrenken H;
Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(4):465-71.
2009: Damoiseaux Jessica S; Smith Stephen M; Witter Menno P; Sanz-Arigita Ernesto J; Barkhof Frederik; Scheltens Philip; Stam Cornelis J; Zarei Mojtaba; Rombouts Serge A R B
White matter tract integrity in aging and Alzheimer's disease.
Human brain mapping 2009;30(4):1051-9.
2009: Henneman W J P; Sluimer J D; Barnes J; van der Flier W M; Sluimer I C; Fox N C; Scheltens P; Vrenken H; Barkhof F
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.
Neurology 2009;72(11):999-1007.
2009: Zarei Mojtaba; Damoiseaux Jeske S; Morgese Ciro; Beckmann Christian F; Smith Steve M; Matthews Paul M; Scheltens Philip; Rombouts Serge A R B; Barkhof Frederik
Regional white matter integrity differentiates between vascular dementia and Alzheimer disease.
Stroke; a journal of cerebral circulation 2009;40(3):773-9.
2009: Tolboom Nelleke; Yaqub Maqsood; van der Flier Wiesje M; Boellaard Ronald; Luurtsema Gert; Windhorst Albert D; Barkhof Frederik; Scheltens Philip; Lammertsma Adriaan A; van Berckel Bart N M
Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(2):191-7.
2009: Ropele Stefan; Seewann Alexandra; Gouw Alida A; van der Flier Wiesje M; Schmidt Reinhold; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo; Scheltens Philip; Wahlund Lars O; Waldemar Gunhild; Chabriat Hugues; Ferro José; Hennerici Michael; O'Brien John; Wallin Anders; Langhorne Peter; Visser Marieke C; Barkhof Frederik; Fazekas Franz;
Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion-weighted and magnetization transfer imaging: the LADIS (Leukoaraiosis and Disability in the Elderly) study.
Journal of magnetic resonance imaging : JMRI 2009;29(2):268-74.
2009: Henneman Wouter J P; Sluimer Jasper D; Cordonnier Charlotte; Baak Merel M E; Scheltens Philip; Barkhof Frederik; van der Flier Wiesje M
MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population.
Stroke; a journal of cerebral circulation 2009;40(2):492-8.
2009: Bot Joseph C J; Barkhof Frederik
Spinal-cord MRI in multiple sclerosis: conventional and nonconventional MR techniques.
Neuroimaging clinics of North America 2009;19(1):81-99.
2009: Moraal Bastiaan; Meier Dominik S; Poppe Peter A; Geurts Jeroen J G; Vrenken Hugo; Jonker William M A; Knol Dirk L; van Schijndel Ronald A; Pouwels Petra J W; Pohl Christoph; Bauer Lars; Sandbrink Rupert; Guttmann Charles R G; Barkhof Frederik
Subtraction MR images in a multiple sclerosis multicenter clinical trial setting.
Radiology 2009;250(2):506-14.
2009: Roosendaal S D; Geurts J J G; Vrenken H; Hulst H E; Cover K S; Castelijns J A; Pouwels P J W; Barkhof F
Regional DTI differences in multiple sclerosis patients.
NeuroImage 2009;44(4):1397-403.
2009: Rombouts Serge A R B; Damoiseaux Jessica S; Goekoop Rutger; Barkhof Frederik; Scheltens Philip; Smith Stephen M; Beckmann Christian F
Model-free group analysis shows altered BOLD FMRI networks in dementia.
Human brain mapping 2009;30(1):256-66.
2009: Inzitari Domenico; Pracucci Giovanni; Poggesi Anna; Carlucci Giovanna; Barkhof Frederik; Chabriat Hugues; Erkinjuntti Timo; Fazekas Franz; Ferro José M; Hennerici Michael; Langhorne Peter; O'Brien John; Scheltens Philip; Visser Marieke C; Wahlund Lars-Olof; Waldemar Gunhild; Wallin Anders; Pantoni Leonardo;
Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort.
BMJ (Clinical research ed.) 2009;339():b2477.
2009: Nielsen Jessica M; Pohl Christoph; Polman Chris H; Barkhof Frederik; Freedman Mark S; Edan Gilles; Miller David H; Bauer Lars; Sandbrink Rupert; Kappos Ludwig; Uitdehaag Bernard M J
MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome.
BMC neurology 2009;9():19.
2009: Jokinen Hanna; Kalska Hely; Ylikoski Raija; Madureira Sofia; Verdelho Ana; van der Flier Wiesje M; Scheltens Philip; Barkhof Frederik; Visser Marieke C; Fazekas Franz; Schmidt Reinhold; O'Brien John; Waldemar Gunhild; Wallin Anders; Chabriat Hugues; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo;
Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study.
Cerebrovascular diseases (Basel, Switzerland) 2009;27(4):384-91.
2009: Jokinen Hanna; Kalska Hely; Ylikoski Raija; Madureira Sofia; Verdelho Ana; Gouw Alida; Scheltens Philip; Barkhof Frederik; Visser Marieke C; Fazekas Franz; Schmidt Reinhold; O'Brien John; Hennerici Michael; Baezner Hansjorg; Waldemar Gunhild; Wallin Anders; Chabriat Hugues; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo;
MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study.
Cerebrovascular diseases (Basel, Switzerland) 2009;27(4):336-44.
2008: Vermeulen R Jeroen; van Schie Petra E M; Hendrikx Lotte; Barkhof Frederik; van Weissenbruch Mirjam; Knol Dirk L; Pouwels Petra J W
Diffusion-weighted and conventional MR imaging in neonatal hypoxic ischemia: two-year follow-up study.
Radiology 2008;249(2):631-9.
2008: Gouw Alida A; van der Flier Wiesje M; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo; Wahlund Lars O; Waldemar Gunhild; Schmidt Reinhold; Fazekas Franz; Scheltens Philip; Barkhof Frederik;
On the etiology of incident brain lacunes: longitudinal observations from the LADIS study.
Stroke; a journal of cerebral circulation 2008;39(11):3083-5.
2008: Staekenborg S S; van Straaten E C W; van der Flier W M; Lane R; Barkhof F; Scheltens P
Small vessel versus large vessel vascular dementia: risk factors and MRI findings.
Journal of neurology 2008;255(11):1644-51; discussion 1813-4.
2008: Mikol Daniel D; Barkhof Frederik; Chang Peter; Coyle Patricia K; Jeffery Douglas R; Schwid Steven R; Stubinski Bettina; Uitdehaag Bernard M J;
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial.
Lancet neurology 2008;7(10):903-14.
2008: de Jonge Rogier C J; Swart Joost F; Koomen Irene; Rombouts Serge A R B; Gemke Reinoud J B J; Barkhof Frederik; van Furth A Marceline
No structural cerebral differences between children with a history of bacterial meningitis and healthy siblings.
Acta paediatrica (Oslo, Norway : 1992) 2008;97(10):1390-6.
2008: Moraal Bastiaan; Roosendaal Stefan D; Pouwels Petra J W; Vrenken Hugo; van Schijndel Ronald A; Meier Dominik S; Guttmann Charles R G; Geurts Jeroen J G; Barkhof Frederik
Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis.
European radiology 2008;18(10):2311-20.
2008: Neacsu Veronica; Jasperse Bas; Korteweg Tijmen; Knol Dirk L; Valsasina Paola; Filippi Massimo; Barkhof Frederik; Rovaris Marco; Vrenken Hugo;
Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA.
Journal of magnetic resonance imaging : JMRI 2008;28(3):559-65.
2008: Geurts Jeroen J G; Barkhof Frederik
Grey matter pathology in multiple sclerosis.
Lancet neurology 2008;7(9):841-51.
2008: Bosnell R; Wegner C; Kincses Z T; Korteweg T; Agosta F; Ciccarelli O; De Stefano N; Gass A; Hirsch J; Johansen-Berg H; Kappos L; Barkhof F; Mancini L; Manfredonia F; Marino S; Miller D H; Montalban X; Palace J; Rocca M; Enzinger C; Ropele S; Rovira A; Smith S; Thompson A; Thornton J; Yousry T; Whitcher B; Filippi M; Matthews P M
Reproducibility of fMRI in the clinical setting: implications for trial designs.
NeuroImage 2008;42(2):603-10.
2008: Sluimer Jasper D; van der Flier Wiesje M; Karas Giorgos B; Fox Nick C; Scheltens Philip; Barkhof Frederik; Vrenken Hugo
Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients.
Radiology 2008;248(2):590-8.
2008: Bastos-Leite A J; Kuijer J P A; Rombouts S A R B; Sanz-Arigita E; van Straaten E C; Gouw A A; van der Flier W M; Scheltens P; Barkhof F
Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities.
AJNR. American journal of neuroradiology 2008;29(7):1296-301.
2008: Minneboo A; Jasperse B; Barkhof F; Uitdehaag B M J; Knol D L; de Groot V; Polman C H; Castelijns J A
Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters.
Journal of neurology, neurosurgery, and psychiatry 2008;79(8):917-23.
2008: Frisoni Giovanni B; Henneman Wouter J P; Weiner Michael W; Scheltens Philip; Vellas Bruno; Reynish Emma; Hudecova Jaroslava; Hampel Harald; Burger Katharina; Blennow Kaj; Waldemar Gunhild; Johannsen Peter; Wahlund Lars-Olof; Zito Giancarlo; Rossini Paolo M; Winblad Bengt; Barkhof Frederik;
The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2008;4(4):255-64.
2008: van den Elskamp I J; Lembcke J; Dattola V; Beckmann K; Pohl C; Hong W; Sandbrink R; Wagner K; Knol D L; Uitdehaag B; Barkhof F
Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(6):764-9.
2008: Bakshi Rohit; Thompson Alan J; Rocca Maria A; Pelletier Daniel; Dousset Vincent; Barkhof Frederik; Inglese Matilde; Guttmann Charles R G; Horsfield Mark A; Filippi Massimo
MRI in multiple sclerosis: current status and future prospects.
Lancet neurology 2008;7(7):615-25.
2008: Dyrby Tim B; Rostrup Egill; Baaré William F C; van Straaten Elisabeth C W; Barkhof Frederik; Vrenken Hugo; Ropele Stefan; Schmidt Reinhold; Erkinjuntti Timo; Wahlund Lars-Olof; Pantoni Leonardo; Inzitari Domenico; Paulson Olaf B; Hansen Lars Kai; Waldemar Gunhild;
Segmentation of age-related white matter changes in a clinical multi-center study.
NeuroImage 2008;41(2):335-45.
2008: Khaleeli Zhaleh; Ciccarelli Olga; Manfredonia Francesco; Barkhof Frederik; Brochet Bruno; Cercignani Mara; Dousset Vincent; Filippi Massimo; Montalban Xavier; Polman Chris; Rovaris Marco; Rovira Alex; Sastre-Garriga Jaume; Vellinga Machteld; Miller David; Thompson Alan
Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study.
Annals of neurology 2008;63(6):790-3.
2008: Sluimer J D; Vrenken H; Blankenstein M A; Fox N C; Scheltens P; Barkhof F; van der Flier W M
Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors.
Neurology 2008;70(19 Pt 2):1836-41.
2008: Wessels Alette M; Scheltens Philip; Barkhof Frederik; Heine Robert J
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
European journal of pharmacology 2008;585(1):88-96.
2008: Gouw Alida A; van der Flier Wiesje M; Fazekas Franz; van Straaten Elisabeth C W; Pantoni Leonardo; Poggesi Anna; Inzitari Domenico; Erkinjuntti Timo; Wahlund Lars O; Waldemar Gunhild; Schmidt Reinhold; Scheltens Philip; Barkhof Frederik;
Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
Stroke; a journal of cerebral circulation 2008;39(5):1414-20.
2008: Karas G; Sluimer J; Goekoop R; van der Flier W; Rombouts S A R B; Vrenken H; Scheltens P; Fox N; Barkhof F
Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease.
AJNR. American journal of neuroradiology 2008;29(5):944-9.
2008: Meijer O W M; Weijmans E J; Knol D L; Slotman B J; Barkhof F; Vandertop W P; Castelijns J A
Tumor-volume changes after radiosurgery for vestibular schwannoma: implications for follow-up MR imaging protocol.
AJNR. American journal of neuroradiology 2008;29(5):906-10.
2008: Rovaris Marco; Judica Elda; Sastre-Garriga Jaume; Rovira Alex; Sormani Maria Pia; Benedetti Beatrice; Korteweg Tijmen; De Stefano Nicola; Khaleeli Zhaleh; Montalban Xavier; Barkhof Frederik; Miller David H; Polman Chris; Thompson Alan J; Filippi Massimo
Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(4):455-64.
2008: Schoonenboom Niki S M; van der Flier Wiesje M; Blankenstein Marinus A; Bouwman Femke H; Van Kamp Gerard J; Barkhof Frederik; Scheltens Philip
CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.
Neurobiology of aging 2008;29(5):669-75.
2008: Roosendaal Stefan D; Moraal Bastiaan; Vrenken Hugo; Castelijns Jonas A; Pouwels Petra J W; Barkhof Frederik; Geurts Jeroen J G
In vivo MR imaging of hippocampal lesions in multiple sclerosis.
Journal of magnetic resonance imaging : JMRI 2008;27(4):726-31.
2008: Zwemmer J N P; Bot J C J; Jelles B; Barkhof F; Polman C H
At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities only.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(3):428-30.
2008: Staekenborg Salka S; Gillissen Freek; Romkes Rolinka; Pijnenburg Yolande A L; Barkhof Frederik; Scheltens Philip; van der Flier Wiesje M
Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
International journal of geriatric psychiatry 2008;23(4):387-92.
2008: Polman C H; Reingold S C; Barkhof F; Calabresi P A; Clanet M; Cohen J A; Cutter G R; Freedman M S; Kappos L; Lublin F D; McFarland H F; Metz L M; Miller A E; Montalban X; O'Connor P W; Panitch H; Richert J R; Petkau J; Schwid S R; Sormani M P; Thompson A J; Weinshenker B G; Wolinsky J S
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
Neurology 2008;70(13 Pt 2):1134-40.
2008: Vellinga Machteld M; Oude Engberink Raoul D; Seewann Alexandra; Pouwels Petra J W; Wattjes Mike P; van der Pol Susanne M A; Pering Christiane; Polman Chris H; de Vries Helga E; Geurts Jeroen J G; Barkhof Frederik
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement.
Brain : a journal of neurology 2008;131(Pt 3):800-7.
2008: Vellinga M M; Castelijns J A; Barkhof F; Uitdehaag B M J; Polman C H
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients.
Neurology 2008;70(13 Pt 2):1150-1.
2008: Duan Y; Hildenbrand P G; Sampat M P; Tate D F; Csapo I; Moraal B; Bakshi R; Barkhof F; Meier D S; Guttmann C R G
Segmentation of subtraction images for the measurement of lesion change in multiple sclerosis.
AJNR. American journal of neuroradiology 2008;29(2):340-6.
2008: Geurts Jeroen J G; Blezer Erwin L A; Vrenken Hugo; van der Toorn Annette; Castelijns Jonas A; Polman Chris H; Pouwels Petra J W; Bö Lars; Barkhof Frederik
Does high-field MR imaging improve cortical lesion detection in multiple sclerosis?
Journal of neurology 2008;255(2):183-91.
2008: Staekenborg Salka S; van der Flier Wiesje M; van Straaten Elisabeth C W; Lane Roger; Barkhof Frederik; Scheltens Philip
Neurological signs in relation to type of cerebrovascular disease in vascular dementia.
Stroke; a journal of cerebral circulation 2008;39(2):317-22.
2008: Seewann A; Enzinger C; Filippi M; Barkhof F; Rovira A; Gass A; Miller D; Montalban X; Thompson A; Yousry T; Tintore M; de Stefano N; Palace J; Rovaris M; Polman C; Fazekas F;
MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.
Journal of neurology 2008;255(1):1-10.
2008: Karas Giorgos; Scheltens Philip; Barkhof Frederik
Feature extraction and strategy of analyzing structural neuroimaging in dementia.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2008;89():75-86.
2008: Gouw A A; van der Flier W M; van Straaten E C W; Pantoni L; Bastos-Leite A J; Inzitari D; Erkinjuntti T; Wahlund L O; Ryberg C; Schmidt R; Fazekas F; Scheltens P; Barkhof F;
Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression.
Cerebrovascular diseases (Basel, Switzerland) 2008;25(3):247-53.
2007: Bastos-Leite António J; van der Flier Wiesje M; van Straaten Elisabeth C W; Staekenborg Salka S; Scheltens Philip; Barkhof Frederik
The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia.
Stroke; a journal of cerebral circulation 2007;38(12):3182-5.
2007: Karas Giorgos; Scheltens Philip; Rombouts Serge; van Schijndel Ronald; Klein Martin; Jones Bethany; van der Flier Wiesje; Vrenken Hugo; Barkhof Frederik
Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study.
Neuroradiology 2007;49(12):967-76.
2007: Rombouts Serge A R B; Scheltens Philip; Kuijer Joost P A; Barkhof Frederik
Whole brain analysis of T2* weighted baseline FMRI signal in dementia.
Human brain mapping 2007;28(12):1313-7.
2007: Jasperse Bas; Vrenken Hugo; Sanz-Arigita Ernesto; de Groot Vincent; Smith Stephen M; Polman Chris H; Barkhof Frederik
Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis.
NeuroImage 2007;38(3):529-37.
2007: Barkhof F; Polvikoski T M; van Straaten E C W; Kalaria R N; Sulkava R; Aronen H J; Niinistö L; Rastas S; Oinas M; Scheltens P; Erkinjuntti T
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old.
Neurology 2007;69(15):1521-7.
2007: van de Pol L A; van der Flier W M; Korf E S C; Fox N C; Barkhof F; Scheltens P
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.
Neurology 2007;69(15):1491-7.
2007: Jasperse Bas; Valsasina Paola; Neacsu Veronica; Knol Dirk L; De Stefano Nicola; Enzinger Christian; Smith Stephen M; Ropele Stefan; Korteweg Tijmen; Giorgio Antonio; Anderson Valerie; Polman Chris H; Filippi Massimo; Miller David H; Rovaris Marco; Barkhof Frederik; Vrenken Hugo;
Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX.
Journal of magnetic resonance imaging : JMRI 2007;26(4):881-5.
2007: Hagenbeek R E; Rombouts S A R B; Veltman D J; Van Strien J W; Witter M P; Scheltens P; Barkhof F
Nonlinear changes in brain activity during continuous word repetition: an event-related multiparametric functional MR imaging study.
AJNR. American journal of neuroradiology 2007;28(9):1715-21.
2007: van Veen Tineke; Nielsen Jessica; Berkhof Johannes; Barkhof Frederik; Kamphorst Wouter; Bö Lars; Ravid Rivka; Verweij Cor L; Huitinga Inge; Polman Chris H; Uitdehaag Bernard M J
CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis.
Journal of neuroimmunology 2007;190(1-2):157-64.
2007: Liedorp M; Sanchez E; van Hoogstraten I M W; von Blomberg B M E; Barkhof F; Polman C H; Killestein J
No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up.
Journal of neurology, neurosurgery, and psychiatry 2007;78(10):1146-8.
2007: Barkhof Frederik; Polman Chris H; Radue Ernst-Wilhelm; Kappos Ludwig; Freedman Mark S; Edan Gilles; Hartung Hans-Peter; Miller David H; Montalbán Xavier; Poppe Peter; de Vos Marlieke; Lasri Fatiha; Bauer Lars; Dahms Susanne; Wagner Klaus; Pohl Christoph; Sandbrink Rupert
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
Archives of neurology 2007;64(9):1292-8.
2007: Geurts Jeroen J G; Bö Lars; Roosendaal Stefan D; Hazes Thierry; Daniëls Richard; Barkhof Frederik; Witter Menno P; Huitinga Inge; van der Valk Paul
Extensive hippocampal demyelination in multiple sclerosis.
Journal of neuropathology and experimental neurology 2007;66(9):819-27.
2007: Kappos Ludwig; Freedman Mark S; Polman Chris H; Edan Gilles; Hartung Hans-Peter; Miller David H; Montalbán Xavier; Barkhof Frederik; Radü Ernst-Wilhelm; Bauer Lars; Dahms Susanne; Lanius Vivian; Pohl Christoph; Sandbrink Rupert;
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study.
Lancet 2007;370(9585):389-97.
2007: Swanton Josephine K; Rovira Alex; Tintore Mar; Altmann Daniel R; Barkhof Frederik; Filippi Massimo; Huerga Elena; Miszkiel Katherine A; Plant Gordon T; Polman Chris; Rovaris Marco; Thompson Alan J; Montalban Xavier; Miller David H
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.
Lancet neurology 2007;6(8):677-86.
2007: Wessels A M; Rombouts S A R B; Remijnse P L; Boom Y; Scheltens P; Barkhof F; Heine R J; Snoek F J
Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume.
Diabetologia 2007;50(8):1763-9.
2007: van de Pol Laura A; Korf Esther S C; van der Flier Wiesje M; Brashear H Robert; Fox Nick C; Barkhof Frederik; Scheltens Philip
Magnetic resonance imaging predictors of cognition in mild cognitive impairment.
Archives of neurology 2007;64(7):1023-8.
2007: Nielsen J M; Moraal B; Polman C H; Poppe P; de Vos M; Freedman M S; Kappos L; Barkhof F; Bauer L; Pohl C; Sandbrink R; Hartung H-P; Uitdehaag B M J
Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging results.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(6):717-21.
2007: Vrenken H; Pouwels P J W; Ropele S; Knol D L; Geurts J J G; Polman C H; Barkhof F; Castelijns J A
Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(6):708-16.
2007: Bouwman F H; Schoonenboom S N M; van der Flier W M; van Elk E J; Kok A; Barkhof F; Blankenstein M A; Scheltens Ph
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.
Neurobiology of aging 2007;28(7):1070-4.
2007: Mulder Cees; van der Flier Wiesje M; Veerhuis Robert; Bouwman Femke; Jakobs Cornelis; Verhoeven Nanda M; Barkhof Frederik; Scheltens Philip; Blankenstein Marinus A
Association between vitamin B6 and white matter hyperintensities in patients with Alzheimer's disease not mediated by homocysteine metabolism.
Journal of the American Geriatrics Society 2007;55(6):956-8.
2007: Kalkers N F; Strijers R L M; Jasperse M M S; Neacsu V; Geurts J J G; Barkhof F; Polman C H; Stam C J
Motor evoked potential: a reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRI.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2007;118(6):1332-40.
2007: Ryberg C; Rostrup E; Stegmann M B; Barkhof F; Scheltens P; van Straaten E C W; Fazekas F; Schmidt R; Ferro J M; Baezner H; Erkinjuntti T; Jokinen H; Wahlund L-O; O'brien J; Basile A M; Pantoni L; Inzitari D; Waldemar G;
Clinical significance of corpus callosum atrophy in a mixed elderly population.
Neurobiology of aging 2007;28(6):955-63.
2007: Jasperse Bas; Jakobs Cornelis; Eikelenboom M Judith; Dijkstra Christine D; Uitdehaag Bernard M J; Barkhof Frederik; Polman Chris H; Teunissen Charlotte E
N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry.
Journal of neurology 2007;254(5):631-7.
2007: van Winsen L M L; Hooper-van Veen T; van Rossum E F C; Koper J W; Barkhof F; Polman C H; Uitdehaag B M J
Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS.
Journal of neuroimmunology 2007;186(1-2):150-5.
2007: Gerards F A; Twisk J W R; Bakker M; Barkhof F; van Vugt J M G
Fetal lung volume: three-dimensional ultrasonography compared with magnetic resonance imaging.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2007;29(5):533-6.
2007: Jokinen Hanna; Ryberg Charlotte; Kalska Hely; Ylikoski Raija; Rostrup Egill; Stegmann Mikkel B; Waldemar Gunhild; Madureira Sofia; Ferro José M; van Straaten Elizabeth C W; Scheltens Philip; Barkhof Frederik; Fazekas Franz; Schmidt Reinhold; Carlucci Giovanna; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo;
Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study.
Journal of neurology, neurosurgery, and psychiatry 2007;78(5):491-6.
2007: van Schie P E M; Becher J G; Dallmeijer A J; Barkhof F; Weissenbruch M M; Vermeulen R J
Motor outcome at the age of one after perinatal hypoxic-ischemic encephalopathy.
Neuropediatrics 2007;38(2):71-7.
2007: van der Flier Wiesje M; Barkhof Frederik; Scheltens Philip
Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI.
Annals of the New York Academy of Sciences 2007;1097():215-24.
2007: Jasperse Bas; Minneboo Arjan; de Groot Vincent; Kalkers Nynke F; van Helden Paul E; Uitdehaag Bernard M J; Barkhof Frederik; Polman Chris H
Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis.
Archives of neurology 2007;64(2):190-4.
2007: Korf E S C; van Straaten E C W; de Leeuw F-E; van der Flier W M; Barkhof F; Pantoni L; Basile A M; Inzitari D; Erkinjuntti T; Wahlund L-O; Rostrup E; Schmidt R; Fazekas F; Scheltens P;
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study.
Diabetic medicine : a journal of the British Diabetic Association 2007;24(2):166-71.
2007: van de Pol L A; Barnes J; Scahill R I; Frost C; Lewis E B; Boyes R G; van Schijndel R A; Scheltens P; Fox N C; Barkhof F
Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registration.
NeuroImage 2007;34(3):1036-41.
2007: Kuhle Jens; Pohl Christoph; Mehling Matthias; Edan Gilles; Freedman Mark S; Hartung Hans-Peter; Polman Chris H; Miller David H; Montalban Xavier; Barkhof Frederik; Bauer Lars; Dahms Susanne; Lindberg Raija; Kappos Ludwig; Sandbrink Rupert
Lack of association between antimyelin antibodies and progression to multiple sclerosis.
The New England journal of medicine 2007;356(4):371-8.
2007: Inzitari Domenico; Simoni Michela; Pracucci Giovanni; Poggesi Anna; Basile Anna Maria; Chabriat Hugues; Erkinjuntti Timo; Fazekas Franz; Ferro José M; Hennerici Michael; Langhorne Peter; O'Brien John; Barkhof Frederik; Visser Marieke C; Wahlund Lars-Olof; Waldemar Gunhild; Wallin Anders; Pantoni Leonardo;
Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study.
Archives of internal medicine 2007;167(1):81-8.
2007: Bö Lars; Geurts Jeroen J G; van der Valk Paul; Polman Chris; Barkhof Frederik
Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.
Archives of neurology 2007;64(1):76-80.
2007: Buis Dennis R; Lagerwaard Frank J; Dirven Clemens M F; Barkhof Frederik; Knol Dirk L; van den Berg René; Slotman Ben J; Vandertop W Peter
Delineation of brain AVMs on MR-Angiography for the purpose of stereotactic radiosurgery.
International journal of radiation oncology, biology, physics 2007;67(1):308-16.
2007: van Stegeren Anda H; Wolf Oliver T; Everaerd Walter; Scheltens Philip; Barkhof Frederik; Rombouts Serge A R B
Endogenous cortisol level interacts with noradrenergic activation in the human amygdala.
Neurobiology of learning and memory 2007;87(1):57-66.
2007: Korteweg Tijmen; Uitdehaag Bernard M J; Knol Dirk L; Smithuis Robin H M; Algra Paul R; de Vries Cees; Poppe Peter A; van Waesberghe Jan-Hein T M; Bergers Elisabeth; Lycklama à Nijeholt Geert J; Polman Chris H; Barkhof Frederik
Interobserver agreement on the radiological criteria of the International Panel on the diagnosis of multiple sclerosis.
European radiology 2007;17(1):67-71.
2007: Jongen Peter J H; Lycklama a Nijeholt Geert; Lamers Karel J B; Doesburg Wim H; Barkhof Frederik; Lemmens Wim A J G; Klasen Ina S; Hommes Otto R
Cerebrospinal fluid IgM index correlates with cranial MRI lesion load in patients with multiple sclerosis.
European neurology 2007;58(2):90-5.
2007: Ylikoski Raija; Jokinen Hanna; Andersen Pia; Salonen Oili; Madureira Sofia; Ferro Jose; Barkhof Frederik; van der Flier Wiesje; Schmidt Reinhold; Fazekas Franz; Scheltens Philip; Waldemar Gunhild; Salvadori Emilia; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo;
Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.
Dementia and geriatric cognitive disorders 2007;24(2):73-81.
2006: Lazeron R H C; de Sonneville L M J; Scheltens P; Polman C H; Barkhof F
Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(6):760-8.
2006: Pouwels Petra J W; Kuijer Joost P A; Mugler John P; Guttmann Charles R G; Barkhof Frederik
Human gray matter: feasibility of single-slab 3D double inversion-recovery high-spatial-resolution MR imaging.
Radiology 2006;241(3):873-9.
2006: Bastos-Leite A J; van Waesberghe J H; Oen A L; van der Flier W M; Scheltens P; Barkhof F
Hippocampal sulcus width and cavities: comparison between patients with Alzheimer disease and nondemented elderly subjects.
AJNR. American journal of neuroradiology 2006;27(10):2141-5.
2006: van der Voorn J Patrick; Pouwels Petra J W; Hart Augustinus A M; Serrarens Judith; Willemsen Michèl A A P; Kremer Hubertus P H; Barkhof Frederik; van der Knaap Marjo S
Childhood white matter disorders: quantitative MR imaging and spectroscopy.
Radiology 2006;241(2):510-7.
2006: Zwemmer J N P; Berkhof J; Castelijns J A; Barkhof F; Polman C H; Uitdehaag B M J
Classification of multiple sclerosis patients by latent class analysis of magnetic resonance imaging characteristics.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(5):565-72.
2006: Vrenken H; Geurts J J G; Knol D L; Polman C H; Castelijns J A; Pouwels P J W; Barkhof F
Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis.
AJNR. American journal of neuroradiology 2006;27(9):2005-11.
2006: Charil Arnaud; Yousry Tarek A; Rovaris Marco; Barkhof Frederik; De Stefano Nicola; Fazekas Franz; Miller David H; Montalban Xavier; Simon Jack H; Polman Chris; Filippi Massimo
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".
Lancet neurology 2006;5(10):841-52.
2006: Kappos L; Polman C H; Freedman M S; Edan G; Hartung H P; Miller D H; Montalban X; Barkhof F; Bauer L; Jakobs P; Pohl C; Sandbrink R
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Neurology 2006;67(7):1242-9.
2006: Wessels A M; Simsek S; Remijnse P L; Veltman D J; Biessels G J; Barkhof F; Scheltens P; Snoek F J; Heine R J; Rombouts S A R B
Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy.
Diabetologia 2006;49(10):2474-80.
2006: Gouw A A; Van der Flier W M; van Straaten E C W; Barkhof F; Ferro J M; Baezner H; Pantoni L; Inzitari D; Erkinjuntti T; Wahlund L O; Waldemar G; Schmidt R; Fazekas F; Scheltens Ph;
Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study.
Journal of neurology 2006;253(9):1189-96.
2006: de Leeuw Frank-Erik; Korf Esther; Barkhof Frederik; Scheltens Philip
White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease.
Stroke; a journal of cerebral circulation 2006;37(9):2248-52.
2006: Vrenken Hugo; Geurts Jeroen J G; Knol Dirk L; van Dijk L Noor; Dattola Vincenzo; Jasperse Bas; van Schijndel Ronald A; Polman Chris H; Castelijns Jonas A; Barkhof Frederik; Pouwels Petra J W
Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter.
Radiology 2006;240(3):811-20.
2006: Wu Ying; Warfield Simon K; Tan I Leng; Wells William M; Meier Dominik S; van Schijndel Ronald A; Barkhof Frederik; Guttmann Charles R G
Automated segmentation of multiple sclerosis lesion subtypes with multichannel MRI.
NeuroImage 2006;32(3):1205-15.
2006: Pantoni Leonardo; Poggesi Anna; Basile Anna Maria; Pracucci Giovanni; Barkhof Frederik; Chabriat Hugues; Erkinjuntti Timo; Ferro José M; Hennerici Michael; O'Brien John; Schmidt Reinhold; Visser Marieke C; Wahlund Lars-Olof; Waldemar Gunhild; Wallin Anders; Inzitari Domenico;
Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study.
Journal of the American Geriatrics Society 2006;54(7):1095-101.
2006: Goekoop Rutger; Barkhof Frederik; Duschek Erik J J; Netelenbos Coen; Knol Dirk L; Scheltens Philip; Rombouts Serge A R B
Raloxifene treatment enhances brain activation during recognition of familiar items: a pharmacological fMRI study in healthy elderly males.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(7):1508-18.
2006: Teunissen C E; Dijkstra C D; Jasperse B; Barkhof F; Vanderstichele H; Vanmechelen E; Polman C H; Bö L
Growth-associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis.
Neuropathology and applied neurobiology 2006;32(3):318-31.
2006: Nielsen Jessica M; Barkhof Frederik; van Oosten Bob W; Polman Chris H
The role of spinal cord imaging in the diagnosis of multiple sclerosis.
Nature clinical practice. Neurology 2006;2(5):283-6; quiz 287.
2006: Li D K B; Held U; Petkau J; Daumer M; Barkhof F; Fazekas F; Frank J A; Kappos L; Miller D H; Simon J H; Wolinsky J S; Filippi M;
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability.
Neurology 2006;66(9):1384-9.
2006: Cordonnier C; van der Flier W M; Sluimer J D; Leys D; Barkhof F; Scheltens P
Prevalence and severity of microbleeds in a memory clinic setting.
Neurology 2006;66(9):1356-60.
2006: Vrenken Hugo; Pouwels Petra J W; Geurts Jeroen J G; Knol Dirk L; Polman Chris H; Barkhof Frederik; Castelijns Jonas A
Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration.
Journal of magnetic resonance imaging : JMRI 2006;23(5):628-36.
2006: Vrenken H; Rombouts S A R B; Pouwels P J W; Barkhof F
Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter.
AJNR. American journal of neuroradiology 2006;27(4):868-74.
2006: van de Pol L A; Hensel A; van der Flier W M; Visser P-J; Pijnenburg Y A L; Barkhof F; Gertz H Josef; Scheltens P
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2006;77(4):439-42.
2006: van der Knaap M S; Kriek M; Overweg-Plandsoen W C G; Hansson K B; Madan K; Starreveld J S; Schotman-Schram P; Barkhof F; Lesnik Oberstein S A M J
Cerebral white matter abnormalities in 6p25 deletion syndrome.
AJNR. American journal of neuroradiology 2006;27(3):586-8.
2006: Yousry Tarek A; Major Eugene O; Ryschkewitsch Caroline; Fahle Gary; Fischer Steven; Hou Jean; Curfman Blanche; Miszkiel Katherine; Mueller-Lenke Nicole; Sanchez Esther; Barkhof Frederik; Radue Ernst-Wilhelm; Jäger Hans R; Clifford David B
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy.
The New England journal of medicine 2006;354(9):924-33.
2006: Korteweg Tijmen; Tintoré Mar; Uitdehaag Bernard; Rovira Alex; Frederiksen Jette; Miller David; Fernando Kryshani; Filippi Massimo; Agosta Federica; Rocca Maria; Fazekas Franz; Enzinger Christian; Matthews Paul; Parry Allyson; Polman Chris; Montalban Xavier; Barkhof Frederik
MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study.
Lancet neurology 2006;5(3):221-7.
2006: Biessels G J; De Leeuw F-E; Lindeboom J; Barkhof F; Scheltens P
Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus.
Journal of neurology, neurosurgery, and psychiatry 2006;77(3):304-7.
2006: Geurts Jeroen J G; Reuling Ilona E W; Vrenken Hugo; Uitdehaag Bernard M J; Polman Chris H; Castelijns Jonas A; Barkhof Frederik; Pouwels Petra J W
MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2006;55(3):478-83.
2006: van Straaten Elisabeth C W; Fazekas Franz; Rostrup Egill; Scheltens Philip; Schmidt Reinhold; Pantoni Leonardo; Inzitari Domenico; Waldemar Gunhild; Erkinjuntti Timo; Mäntylä Riita; Wahlund Lars-Olof; Barkhof Frederik;
Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study.
Stroke; a journal of cerebral circulation 2006;37(3):836-40.
2006: van der Knaap Marjo S; Smit Leo M E; Barkhof Frederik; Pijnenburg Yolande A L; Zweegman Sonja; Niessen Hans W M; Imhof Saskia; Heutink Peter
Neonatal porencephaly and adult stroke related to mutations in collagen IV A1.
Annals of neurology 2006;59(3):504-11.
2006: van der Knaap M S; Ramesh V; Schiffmann R; Blaser S; Kyllerman M; Gholkar A; Ellison D W; van der Voorn J P; van Dooren S J M; Jakobs C; Barkhof F; Salomons G S
Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord.
Neurology 2006;66(4):494-8.
2006: Wessels Alette M; Rombouts Serge A R B; Simsek Suat; Kuijer Joost P A; Kostense Piet J; Barkhof Frederik; Scheltens Philip; Snoek Frank J; Heine Robert J
Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study.
Diabetes 2006;55(2):334-40.
2006: Pijnenburg Y A L; Schoonenboom S N M; Barkhof F; Knol D L; Mulder C; Van Kamp G J; Van Swieten J C; Scheltens P
CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimaging.
Journal of neurology, neurosurgery, and psychiatry 2006;77(2):246-8.
2006: Vos Maaike J; Berkhof Johannes; Postma Tjeerd J; Hoekstra Otto S; Barkhof Frederik; Heimans Jan J
Thallium-201 SPECT: the optimal prediction of response in glioma therapy.
European journal of nuclear medicine and molecular imaging 2006;33(2):222-7.
2006: van de Pol L A; Hensel A; Barkhof F; Gertz H J; Scheltens P; van der Flier W M
Hippocampal atrophy in Alzheimer disease: age matters.
Neurology 2006;66(2):236-8.
2006: Bastos Leite António J; van der Flier Wiesje M; van Straaten Elisabeth C W; Scheltens Philip; Barkhof Frederik
Infratentorial abnormalities in vascular dementia.
Stroke; a journal of cerebral circulation 2006;37(1):105-10.
2006: Goekoop Rutger; Scheltens Philip; Barkhof Frederik; Rombouts Serge A R B
Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
Brain : a journal of neurology 2006;129(Pt 1):141-57.
2006: Semplicini Andrea; Amodio Piero; Leonetti Gastone; Cuspidi Cesare; Umiltà Carlo; Schiff Sami; Scheltens Philip; Barkhof Frederik; Emanueli Costanza; Cagnin Annachiara; Pizzolato Gilberto; Macchini Luisa; Realdi Anna; Royter Vladimir; Bornstein Natan M; Madeddu Paolo
Diagnostic tools for the study of vascular cognitive dysfunction in hypertension and antihypertensive drug research.
Pharmacology & therapeutics 2006;109(1-2):274-83.
2006: Gootjes L; Bouma A; Van Strien J W; Van Schijndel R; Barkhof F; Scheltens Ph
Corpus callosum size correlates with asymmetric performance on a dichotic listening task in healthy aging but not in Alzheimer's disease.
Neuropsychologia 2006;44(2):208-17.
2005: Vos Catharina M P; Geurts Jeroen J G; Montagne Lisette; van Haastert Elise S; Bö Lars; van der Valk Paul; Barkhof Frederik; de Vries Helga E
Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
Neurobiology of disease 2005;20(3):953-60.
2005: Rombouts Serge A R B; Barkhof Frederik; Goekoop Rutger; Stam Cornelis J; Scheltens Philip
Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study.
Human brain mapping 2005;26(4):231-9.
2005: van Ouwerkerk Willem J R; Strijers Rob L M; Barkhof Frederik; Umans Ulco; Vandertop W Peter
Detection of root avulsion in the dominant C7 obstetric brachial plexus lesion: experience with three-dimensional constructive interference in steady-state magnetic resonance imaging and electrophysiology.
Neurosurgery 2005;57(5):930-40; discussion 930-40.
2005: Barkhof F; Held U; Simon J H; Daumer M; Fazekas F; Filippi M; Frank J A; Kappos L; Li D; Menzler S; Miller D H; Petkau J; Wolinsky J;
Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials.
Neurology 2005;65(9):1447-54.
2005: Nielsen Jessica M; Korteweg Tijmen; Barkhof Frederik; Uitdehaag Bernard M J; Polman Chris H
Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria.
Annals of neurology 2005;58(5):781-3.
2005: van der Flier W M; van Straaten E C W; Barkhof F; Ferro J M; Pantoni L; Basile A M; Inzitari D; Erkinjuntti T; Wahlund L O; Rostrup E; Schmidt R; Fazekas F; Scheltens P;
Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study.
Journal of neurology, neurosurgery, and psychiatry 2005;76(11):1497-500.
2005: Lazeron R H C; Boringa J B; Schouten M; Uitdehaag B M J; Bergers E; Lindeboom J; Eikelenboom M I; Scheltens P H; Barkhof F; Polman C H
Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(5):524-31.
2005: van der Flier Wiesje M; van Straaten Elizabeth C W; Barkhof Frederik; Verdelho Ana; Madureira Sofia; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo; Crisby Militta; Waldemar Gunhild; Schmidt Reinhold; Fazekas Franz; Scheltens Philip
Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study.
Stroke; a journal of cerebral circulation 2005;36(10):2116-20.
2005: Lequin Maarten H; Vermeulen Jeroen R; van Elburg Ruurd M; Barkhof Frederik; Kornelisse René F; Swarte Renate; Govaert Paul P
Bacillus cereus meningoencephalitis in preterm infants: neuroimaging characteristics.
AJNR. American journal of neuroradiology 2005;26(8):2137-43.
2005: Sastre-Garriga J; Ingle G T; Rovaris M; Téllez N; Jasperse B; Altmann D R; Benedetti B; Stevenson V L; Cercignani M; Leary S M; Barkhof F; Brochet B; Dousset V; Filippi M; Montalban X; Kalkers N F; Polman C H; Rovira A; Miller D H; Thompson A J
Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data.
Neurology 2005;65(4):633-5.
2005: Minneboo A; Uitdehaag B M J; Ader H J; Barkhof F; Polman C H; Castelijns J A
Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients.
Neurology 2005;65(1):56-61.
2005: Geurts Jeroen J G; Pouwels Petra J W; Uitdehaag Bernard M J; Polman Chris H; Barkhof Frederik; Castelijns Jonas A
Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging.
Radiology 2005;236(1):254-60.
2005: Rombouts Serge A R B; Goekoop Rutger; Stam Cornelis J; Barkhof Frederik; Scheltens Philip
Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease.
NeuroImage 2005;26(4):1078-85.
2005: Van Strien Jan W; Hagenbeek Rogier E; Stam Cornelis J; Rombouts Serge A R B; Barkhof Frederik
Changes in brain electrical activity during extended continuous word recognition.
NeuroImage 2005;26(3):952-9.
2005: Mulder Cees; Scheltens Philip; Barkhof Frederik; Gundy Chad; Verstraeten Rob A; de Leeuw Frank-Erik
Low vitamin B6 levels are associated with white matter lesions in Alzheimer's disease.
Journal of the American Geriatrics Society 2005;53(6):1073-4.
2005: Miller David; Barkhof Frederik; Montalban Xavier; Thompson Alan; Filippi Massimo
Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management.
Lancet neurology 2005;4(6):341-8.
2005: Barkhof Frederik; McKinstry Robert C
Quantifying spinal cord demyelination with magnetic transfer imaging.
Neurology 2005;64(10):1677-8.
2005: Buis Dennis R; Lagerwaard Frank J; Barkhof Frederik; Dirven Clemens M F; Lycklama Geert J; Meijer Otto W M; van den Berg René; Langendijk Hans A; Slotman Ben J; Vandertop W Peter
Stereotactic radiosurgery for brain AVMs: role of interobserver variation in target definition on digital subtraction angiography.
International journal of radiation oncology, biology, physics 2005;62(1):246-52.
2005: Miller David; Barkhof Frederik; Montalban Xavier; Thompson Alan; Filippi Massimo
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis.
Lancet neurology 2005;4(5):281-8.
2005: Korteweg Tijmen; Barkhof Frederik; Uitdehaag Bernard M J; Polman Chris H
How to use spinal cord magnetic resonance imaging in the McDonald diagnostic criteria for multiple sclerosis.
Annals of neurology 2005;57(4):606-7.
2005: de Graaf Pim; Barkhof Frederik; Moll Annette C; Imhof Saskia M; Knol Dirk L; van der Valk Paul; Castelijns Jonas A
Retinoblastoma: MR imaging parameters in detection of tumor extent.
Radiology 2005;235(1):197-207.
2005: Polman C; Barkhof F; Sandberg-Wollheim M; Linde A; Nordle O; Nederman T;
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
Neurology 2005;64(6):987-91.
2005: Geurts Jeroen J G; Bö Lars; Pouwels Petra J W; Castelijns Jonas A; Polman Chris H; Barkhof Frederik
Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.
AJNR. American journal of neuroradiology 2005;26(3):572-7.
2005: van der Voorn J Patrick; Pouwels Petra J W; Kamphorst Wout; Powers James M; Lammens Martin; Barkhof Frederik; van der Knaap Marjo S
Histopathologic correlates of radial stripes on MR images in lysosomal storage disorders.
AJNR. American journal of neuroradiology 2005;26(3):442-6.
2005: van den Heuvel Odile A; Veltman Dick J; Groenewegen Henk J; Cath Danielle C; van Balkom Anton J L M; van Hartskamp Julie; Barkhof Frederik; van Dyck Richard
Frontal-striatal dysfunction during planning in obsessive-compulsive disorder.
Archives of general psychiatry 2005;62(3):301-9.
2005: Goekoop R; Duschek E J J; Knol D L; Barkhof F; Netelenbos C; Scheltens Ph; Rombouts S A R B
Raloxifene exposure enhances brain activation during memory performance in healthy elderly males; its possible relevance to behavior.
NeuroImage 2005;25(1):63-75.
2005: van der Knaap Marjo S; Salomons Gajja S; Li Rong; Franzoni Emilio; Gutiérrez-Solana Luiz González; Smit Leo M E; Robinson Richard; Ferrie Collin D; Cree Bruce; Reddy Alyssa; Thomas Neil; Banwell Brenda; Barkhof Frederik; Jakobs Cornelis; Johnson Anne; Messing Albee; Brenner Michael
Unusual variants of Alexander's disease.
Annals of neurology 2005;57(3):327-38.
2005: Veltman Dick J; de Ruiter Michiel B; Rombouts Serge A R B; Lazeron Richard H C; Barkhof Frederik; Van Dyck Richard; Dolan Raymond J; Phaf R Hans
Neurophysiological correlates of increased verbal working memory in high-dissociative participants: a functional MRI study.
Psychological medicine 2005;35(2):175-85.
2005: Vrenken H; Barkhof F; Uitdehaag B M J; Castelijns J A; Polman C H; Pouwels P J W
MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2005;53(2):256-66.
2005: van Stegeren Anda H; Goekoop Rutger; Everaerd Walter; Scheltens Philip; Barkhof Frederik; Kuijer Joost P A; Rombouts Serge A R B
Noradrenaline mediates amygdala activation in men and women during encoding of emotional material.
NeuroImage 2005;24(3):898-909.
2005: Ropele Stefan; Filippi Massimo; Valsasina Paola; Korteweg Tijmen; Barkhof Frederik; Tofts Paul S; Samson Rebecca; Miller David H; Fazekas Franz
Assessment and correction of B1-induced errors in magnetization transfer ratio measurements.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2005;53(1):134-40.
2005: Eikelenboom M Judith; Killestein Joep; Izeboud Thijs; Kalkers Nynke F; Baars Paul A; van Lier Rene A W; Barkhof Frederik; Uitdehaag Bernard M J; Polman Chris H
Expression of adhesion molecules on peripheral lymphocytes predicts future lesion development in MS.
Journal of neuroimmunology 2005;158(1-2):222-30.
2005: Korf Esther S C; Scheltens Philip; Barkhof Frederik; de Leeuw Frank-Erik
Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?
Dementia and geriatric cognitive disorders 2005;20(6):331-7.
2004: Bastos Leite António J; Scheltens Philip; Barkhof Frederik
Pathological aging of the brain: an overview.
Topics in magnetic resonance imaging : TMRI 2004;15(6):369-89.
2004: Goekoop Rutger; Rombouts Serge A R B; Jonker Cees; Hibbel Anneke; Knol Dirk L; Truyen Luc; Barkhof Frederik; Scheltens Philip
Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study.
NeuroImage 2004;23(4):1450-9.
2004: van Straaten E C W; Scheltens Ph; Barkhof F
MRI and CT in the diagnosis of vascular dementia.
Journal of the neurological sciences 2004;226(1-2):9-12.
2004: Bot Joseph C J; Blezer Erwin L A; Kamphorst Wouter; Lycklama A Nijeholt Geert J; Ader Herman J; Castelijns Jonas A; Ig Klaas Nicolay; Bergers Elisabeth; Ravid Rivka; Polman Chris; Barkhof Frederik
The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results.
Radiology 2004;233(2):531-40.
2004: Rejdak K; Eikelenboom M J; Petzold A; Thompson E J; Stelmasiak Z; Lazeron R H C; Barkhof F; Polman C H; Uitdehaag B M J; Giovannoni G
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.
Neurology 2004;63(8):1439-45.
2004: Filippi Massimo; Rovaris Marco; Inglese Matilde; Barkhof Frederik; De Stefano Nicola; Smith Steve; Comi Giancarlo
Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial.
Lancet 2004;364(9444):1489-96.
2004: Karas G B; Scheltens P; Rombouts S A R B; Visser P J; van Schijndel R A; Fox N C; Barkhof F
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease.
NeuroImage 2004;23(2):708-16.
2004: Lazeron Richard H C; Rombouts Serge A R B; Scheltens Philip; Polman Chris H; Barkhof Frederik
An fMRI study of planning-related brain activity in patients with moderately advanced multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(5):549-55.
2004: Vogt M H J; Floris S; Killestein J; Knol D L; Smits M; Barkhof F; Polman C H; Nagelkerken L
Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients.
Journal of neuroimmunology 2004;155(1-2):155-60.
2004: Schrijver Hans M; Crusius J Bart A; García-González M Asunçion; Polman Chris H; Peña A Salvador; Barkhof Frederik; Uitdehaag Bernard M J
Gender-related association between the TGFB1+869 polymorphism and multiple sclerosis.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2004;24(9):536-42.
2004: Barkhof Frederik
Assessing treatment effects on axonal loss--evidence from MRI monitored clinical trials.
Journal of neurology 2004;251 Suppl 4():IV6-12.
2004: Geurts Jeroen J G; Barkhof Frederik; Castelijns Jonas A; Uitdehaag Bernard M J; Polman Chris H; Pouwels Petra J W
Quantitative 1H-MRS of healthy human cortex, hippocampus, and thalamus: metabolite concentrations, quantification precision, and reproducibility.
Journal of magnetic resonance imaging : JMRI 2004;20(3):366-71.
2004: De Leeuw F-E; Barkhof F; Scheltens P
Alzheimer's disease--one clinical syndrome, two radiological expressions: a study on blood pressure.
Journal of neurology, neurosurgery, and psychiatry 2004;75(9):1270-4.
2004: Schmidt R; Scheltens Ph; Erkinjuntti T; Pantoni L; Markus H S; Wallin A; Barkhof F; Fazekas F
White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease.
Neurology 2004;63(1):139-44.
2004: Zwemmer J N P; van Veen T; van Winsen L; van Kamp G J; Barkhof F; Polman C H; Uitdehaag B M J
No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(3):272-7.
2004: Schrijver H M; Hooper-van Veen T; van Belzen M J; Crusius J B A; Peña A S; Barkhof F; Polman C H; Uitdehaag B M J
Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosis.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2004;31(3):133-40.
2004: Prins N D; van Straaten E C W; van Dijk E J; Simoni M; van Schijndel R A; Vrooman H A; Koudstaal P J; Scheltens P; Breteler M M B; Barkhof F
Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics.
Neurology 2004;62(9):1533-9.
2004: Bö L; Geurts J J G; Ravid R; Barkhof F
Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis.
Neuropathology and applied neurobiology 2004;30(2):106-17.
2004: Floris Sarah; van der Goes Annette; Killestein Joep; Knol Dirk L; Barkhof Frederik; Polman Chris H; Dijkstra Christine D; de Vries Helga E; Meilof Jan F
Monocyte activation and disease activity in multiple sclerosis. A longitudinal analysis of serum MRP8/14 levels.
Journal of neuroimmunology 2004;148(1-2):172-7.
2004: van der Knaap Marjo S; Vermeulen Gerre; Barkhof Frederik; Hart Augustinus A M; Loeber J Gerard; Weel Jan F L
Pattern of white matter abnormalities at MR imaging: use of polymerase chain reaction testing of Guthrie cards to link pattern with congenital cytomegalovirus infection.
Radiology 2004;230(2):529-36.
2004: Bastos Leite António J; van Straaten Elisabeth C W; Scheltens Philip; Lycklama Geert; Barkhof Frederik
Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging.
Stroke; a journal of cerebral circulation 2004;35(2):415-9.
2004: de Leeuw Frank-Erik; Barkhof Frederik; Scheltens Philip
White matter lesions and hippocampal atrophy in Alzheimer's disease.
Neurology 2004;62(2):310-2.
2004: Bot J C J; Barkhof F; Polman C H; Lycklama à Nijeholt G J; de Groot V; Bergers E; Ader H J; Castelijns J A
Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination.
Neurology 2004;62(2):226-33.
2004: Vandenbroucke M W G; Goekoop R; Duschek E J J; Netelenbos J C; Kuijer J P A; Barkhof F; Scheltens Ph; Rombouts S A R B
Interindividual differences of medial temporal lobe activation during encoding in an elderly population studied by fMRI.
NeuroImage 2004;21(1):173-80.
2003: Gerards Franca A; Engels Melanie A J; Barkhof Frederik; van den Dungen Frank A M; Vermeulen R Jeroen; van Vugt John M G
Prenatal diagnosis of aneurysms of the vein of Galen (vena magna cerebri) with conventional sonography, three-dimensional sonography, and magnetic resonance imaging: report of 2 cases.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2003;22(12):1363-8.
2003: Hooper-van Veen Tineke; Schrijver Hans M; Zwiers Antoon; Crusius J Bart A; Knol Dirk L; Kalkers Nynke F; Laine Marja L; Barkhof Frederik; Peña A Salvador; Polman Chris H; Uitdehaag Bernard M J
The interleukin-1 gene family in multiple sclerosis susceptibility and disease course.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(6):535-9.
2003: van Walderveen Marianne A A; van Schijndel Ronald A; Pouwels Petra J W; Polman Chris H; Barkhof Frederik
Multislice T1 relaxation time measurements in the brain using IR-EPI: reproducibility, normal values, and histogram analysis in patients with multiple sclerosis.
Journal of magnetic resonance imaging : JMRI 2003;18(6):656-64.
2003: van Veen T; van Winsen L; Crusius J B A; Kalkers N F; Barkhof F; Peña A S; Polman C H; Uitdehaag B M J
[Alpha]B-crystallin genotype has impact on the multiple sclerosis phenotype.
Neurology 2003;61(9):1245-9.
2003: Rombouts S A R B; Stam C J; Kuijer J P A; Scheltens Ph; Barkhof F
Identifying confounds to increase specificity during a "no task condition". Evidence for hippocampal connectivity using fMRI.
NeuroImage 2003;20(2):1236-45.
2003: Vos Maaike J; Hoekstra Otto S; Barkhof Frederik; Berkhof Johannes; Heimans Jan J; van Groeningen Cees J; Vandertop W Peter; Slotman Ben J; Postma Tjeerd J
Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3559-65.
2003: Killestein Joep; Eikelenboom M Judith; Izeboud Thijs; Kalkers Nynke F; Adèr Herman J; Barkhof Frederik; Van Lier Rene A W; Uitdehaag Bernard M J; Polman Chris H
Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS.
Journal of neuroimmunology 2003;142(1-2):141-8.
2003: Lycklama Geert; Thompson Alan; Filippi Massimo; Miller David; Polman Chris; Fazekas Franz; Barkhof Frederik
Spinal-cord MRI in multiple sclerosis.
Lancet neurology 2003;2(9):555-62.
2003: Lazeron Richard H C; Rombouts Serge A R B; de Sonneville Leo; Barkhof Frederik; Scheltens Philip
A paced visual serial addition test for fMRI.
Journal of the neurological sciences 2003;213(1-2):29-34.
2003: Polman C; Barkhof F; Kappos L; Pozzilli C; Sandbrink R; Dahlke F; Jakobs P; Lorenz A;
Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(4):342-8.
2003: Barkhof Frederik; Bruck Wolfgang; De Groot Corline J A; Bergers Elisabeth; Hulshof Sandra; Geurts Jeroen; Polman Chris H; van der Valk Paul
Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.
Archives of neurology 2003;60(8):1073-81.
2003: van Straaten Elisabeth C W; Scheltens Philip; Knol Dirk L; van Buchem Mark A; van Dijk Ewout J; Hofman Paul A M; Karas Giorgos; Kjartansson Olafur; de Leeuw Frank-Erik; Prins Niels D; Schmidt Reinhold; Visser Marieke C; Weinstein Henry C; Barkhof Frederik
Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study.
Stroke; a journal of cerebral circulation 2003;34(8):1907-12.
2003: van Veen Tineke; Crusius J Bart A; van Winsen Lisa; Xia Bing; Barkhof Frederik; Salvador Peña A; Polman Chris H; Uitdehaag Bernard M J
CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis.
Journal of neuroimmunology 2003;140(1-2):188-93.
2003: Rombouts S A R B; van Swieten J C; Pijnenburg Y A L; Goekoop R; Barkhof F; Scheltens P
Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD.
Neurology 2003;60(12):1904-8.
2003: Barkhof Frederik; Rocca Mara; Francis Gordon; Van Waesberghe Jan-Hein T M; Uitdehaag Bernard M J; Hommes Otto R; Hartung Hans-Peter; Durelli Luca; Edan Gilles; Fernández Oscar; Seeldrayers Pierette; Sørensen Per; Margrie Simon; Rovaris Marco; Comi Giancarlo; Filippi Massimo;
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.
Annals of neurology 2003;53(6):718-24.
2003: Lopatinskaya Luba; van Boxel-Dezaire Anette H H; Barkhof Frederik; Polman Chris H; Lucas Cornelis J; Nagelkerken Lex
The development of clinical activity in relapsing-remitting MS is associated with a decrease of FasL mRNA and an increase of Fas mRNA in peripheral blood.
Journal of neuroimmunology 2003;138(1-2):123-31.
2003: Vermeulen R J; Fetter W P F; Hendrikx L; Van Schie P E M; van der Knaap M S; Barkhof F
Diffusion-weighted MRI in severe neonatal hypoxic ischaemia: the white cerebrum.
Neuropediatrics 2003;34(2):72-6.
2003: Karas G B; Burton E J; Rombouts S A R B; van Schijndel R A; O'Brien J T; Scheltens P h; McKeith I G; Williams D; Ballard C; Barkhof F
A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry.
NeuroImage 2003;18(4):895-907.
2003: Horsfield Mark A; Barker Gareth J; Barkhof Frederik; Miller David H; Thompson Alan J; Filippi Massimo
Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis.
Journal of magnetic resonance imaging : JMRI 2003;17(4):389-97.
2003: Inglese M; van Waesberghe J H T M; Rovaris M; Beckmann K; Barkhof F; Hahn D; Kappos L; Miller D H; Polman C; Pozzilli C; Thompson A J; Yousry T A; Wagner K; Comi G; Filippi M
The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS.
Neurology 2003;60(5):853-60.
2003: Vos M J; Uitdehaag B M J; Barkhof F; Heimans J J; Baayen H C; Boogerd W; Castelijns J A; Elkhuizen P H M; Postma T J
Interobserver variability in the radiological assessment of response to chemotherapy in glioma.
Neurology 2003;60(5):826-30.
2003: van den Heuvel Odile A; Groenewegen Henk J; Barkhof Frederik; Lazeron Richard H C; van Dyck Richard; Veltman Dick J
Frontostriatal system in planning complexity: a parametric functional magnetic resonance version of Tower of London task.
NeuroImage 2003;18(2):367-74.
2003: Lycklama à Nijeholt Geert; Barkhof Frederik
Differences between subgroups of MS: MRI findings and correlation with histopathology.
Journal of the neurological sciences 2003;206(2):173-4.
2003: van der Knaap Marjo S; van der Voorn Patrick; Barkhof Frederik; Van Coster Rudy; Krägeloh-Mann Ingeborg; Feigenbaum Annette; Blaser Susan; Vles Johan S H; Rieckmann Peter; Pouwels Petra J W
A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate.
Annals of neurology 2003;53(2):252-8.
2003: Eikelenboom M J; Petzold A; Lazeron R H C; Silber E; Sharief M; Thompson E J; Barkhof F; Giovannoni G; Polman C H; Uitdehaag B M J
Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy.
Neurology 2003;60(2):219-23.
2003: Barkhof Frederik
Guidelines for brain imaging in vascular dementia clinical trials.
International psychogeriatrics / IPA 2003;15 Suppl 1():273-6.
2003: Scheltens Philip; Barkhof Frederik; Fazekas Franz
White-matter changes on MRI as surrogate marker.
International psychogeriatrics / IPA 2003;15 Suppl 1():261-5.
2002: Kalkers N F; Barkhof F; Bergers E; van Schijndel R; Polman C H
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(6):532-3.
2002: Bergers E; Bot J C J; De Groot C J A; Polman C H; Lycklama à Nijeholt G J; Castelijns J A; van der Valk P; Barkhof F
Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions.
Neurology 2002;59(11):1766-71.
2002: Pantoni Leonardo; Simoni Michela; Pracucci Giovanni; Schmidt Reinhold; Barkhof Frederik; Inzitari Domenico
Visual rating scales for age-related white matter changes (leukoaraiosis): can the heterogeneity be reduced?
Stroke; a journal of cerebral circulation 2002;33(12):2827-33.
2002: Eikelenboom M J; Killestein J; Izeboud T; Kalkers N F; van Lier R A W; Barkhof F; Uitdehaag B M J; Polman C H
Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosis.
Journal of neuroimmunology 2002;133(1-2):225-32.
2002: Rombouts S A R B; Barkhof F; Van Meel C S; Scheltens P
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2002;73(6):665-71.
2002: Hagenbeek Rogier E; Rombouts Serge A R B; van Dijk Bob W; Barkhof Frederik
Determination of individual stimulus--response curves in the visual cortex.
Human brain mapping 2002;17(4):244-50.
2002: Barkhof Frederik
Whole-brain T1-relaxation time measurements in multiple sclerosis.
Journal of neurology 2002;249(10):1451-2.
2002: Burton E J; Karas G; Paling S M; Barber R; Williams E D; Ballard C G; McKeith I G; Scheltens P; Barkhof F; O'Brien J T
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry.
NeuroImage 2002;17(2):618-30.
2002: Kalkers Nynke F; Ameziane Najim; Bot Joost C J; Minneboo Arjan; Polman Chris H; Barkhof Frederik
Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype.
Archives of neurology 2002;59(10):1572-6.
2002: Hoogervorst E L J; Polman C H; Barkhof F
Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(5):415-9.
2002: Kalkers N F; Vrenken H; Uitdehaag B M J; Polman C H; Barkhof F
Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(5):410-4.
2002: Tan I Leng; van Schijndel Ronald A; Pouwels Petra J W; Adèr Herman J; Barkhof Frederik
Serial isotropic three-dimensional fast FLAIR imaging: using image registration and subtraction to reveal active multiple sclerosis lesions.
AJR. American journal of roentgenology 2002;179(3):777-82.
2002: Miller David H; Barkhof Frederik; Frank Joseph A; Parker Geoffrey J M; Thompson Alan J
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance.
Brain : a journal of neurology 2002;125(Pt 8):1676-95.
2002: van Veen T; Kalkers N F; Crusius J B A; van Winsen L; Barkhof F; Jongen P J H; Peña A S; Polman C H; Uitdehaag B M J
The FAS-670 polymorphism influences susceptibility to multiple sclerosis.
Journal of neuroimmunology 2002;128(1-2):95-100.
2002: Tan I Leng; van Schijndel Ronald A; Fazekas Franz; Filippi Massimo; Freitag Peter; Miller David H; Yousry Tarek A; Pouwels Petra J W; Adèr Herman J; Barkhof Frederik
Image registration and subtraction to detect active T(2) lesions in MS: an interobserver study.
Journal of neurology 2002;249(6):767-73.
2002: Barkhof Frederik
The clinico-radiological paradox in multiple sclerosis revisited.
Current opinion in neurology 2002;15(3):239-45.
2002: Scheltens Philip; Fox Nick; Barkhof Frederik; De Carli Charles
Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion.
Lancet neurology 2002;1(1):13-21.
2002: Bergers Elisabeth; Bot Joost C J; van der Valk Paul; Castelijns Jonas A; Lycklama a Nijeholt Geert J; Kamphorst Wouter; Polman Chris H; Blezer Erwin L A; Nicolay Klaas; Ravid Rivka; Barkhof Frederik
Diffuse signal abnormalities in the spinal cord in multiple sclerosis: direct postmortem in situ magnetic resonance imaging correlated with in vitro high-resolution magnetic resonance imaging and histopathology.
Annals of neurology 2002;51(5):652-6.
2002: Tan I Leng; van Schijndel Ronald A; van Walderveen Marianne A A; Quist Marcel; Bos Reinhard; Pouwels Petra J W; Desmedt Pol; Adèr Herman J; Barkhof Frederik
Magnetic resonance image registration in multiple sclerosis: comparison with repositioning error and observer-based variability.
Journal of magnetic resonance imaging : JMRI 2002;15(5):505-10.
2002: Ingle G T; Stevenson V L; Miller D H; Leary S M; Rovaris M; Barkhof F; Brochet B; Dousset V; Filippi M; Montalban X; Kalkers N F; Polman C H; Rovira A; Thompson A J
Two-year follow-up study of primary and transitional progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(2):108-14.
2002: Killestein J; Rep M H G; Meilof J F; Adèr H J; Uitdehaag B M J; Barkhof F; van Lier R A W; Polman C H
Seasonal variation in immune measurements and MRI markers of disease activity in MS.
Neurology 2002;58(7):1077-80.
2002: Bot Joost C J; Barkhof Frederik; Lycklama à Nijeholt Geert; van Schaardenburg Dirkjan; Voskuyl Alexandre E; Ader Herman J; Pijnenburg Jolanda A L; Polman Chris H; Uitdehaag Bernard M J; Vermeulen Erik G J; Castelijns Jonas A
Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging.
Radiology 2002;223(1):46-56.
2002: Killestein Joep; Olsson Tomas; Wallström Erik; Svenningsson Anders; Khademi Mohsen; Blumhardt Lance D; Fagius Jan; Hillert Jan; Landtblom Anne-Marie; Edenius Charlotte; Arfors Leopold; Barkhof Frederik; Polman Chris H
Antibody-mediated suppression of Vbeta5.2/5.3(+) T cells in multiple sclerosis: results from an MRI-monitored phase II clinical trial.
Annals of neurology 2002;51(4):467-74.
2002: Tan I L; Pouwels P J W; van Schijndel R A; Adèr H J; Manoliu R A; Barkhof F
Isotropic 3D fast FLAIR imaging of the brain in multiple sclerosis patients: initial experience.
European radiology 2002;12(3):559-67.
2002: van der Meijs A H C; Tan I L; Barkhof F
Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(1):64-7.
2002: Barkhof Frederik; Scheltens Philip
Imaging of white matter lesions.
Cerebrovascular diseases (Basel, Switzerland) 2002;13 Suppl 2():21-30.
2001: Molyneux P D; Barker G J; Barkhof F; Beckmann K; Dahlke F; Filippi M; Ghazi M; Hahn D; MacManus D; Polman C; Pozzilli C; Kappos L; Thompson A J; Wagner K; Yousry T; Miller D H;
Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.
Neurology 2001;57(12):2191-7.
2001: Brex P A; Molyneux P D; Smiddy P; Barkhof F; Filippi M; Yousry T A; Hahn D; Rolland Y; Salonen O; Pozzilli C; Polman C H; Thompson A J; Kappos L; Miller D H;
The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MS.
Neurology 2001;57(12):2185-90.
2001: Kalkers N F; Bergers E; Castelijns J A; van Walderveen M A; Bot J C; Adèr H J; Polman C H; Barkhof F
Optimizing the association between disability and biological markers in MS.
Neurology 2001;57(7):1253-8.
2001: Tan I L; van Schijndel R A; Fazekas F; Filippi M; Freitag P; Miller D H; Yousry T A; Pouwels P J; Adèr H J; Quist M J; Barkhof F
Improved interobserver agreement for visual detection of active T2 lesions on serial MR scans in multiple sclerosis using image registration.
Journal of neurology 2001;248(9):789-94.
2001: Killestein J; Kalkers N F; Meilof J F; Barkhof F; van Lier R A; Polman C H
TNFalpha production by CD4(+) T cells predicts long-term increase in lesion load on MRI in MS.
Neurology 2001;57(6):1129-31.
2001: Killestein J; Rep M H; Barkhof F; Roos M T; Adèr H J; van Lier R A; Polman C H
Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells.
Journal of neuroimmunology 2001;118(2):286-94.
2001: De Groot C J; Bergers E; Kamphorst W; Ravid R; Polman C H; Barkhof F; van der Valk P
Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions.
Brain : a journal of neurology 2001;124(Pt 8):1635-45.
2001: Rombouts S A; Barkhof F; Witter M P; Machielsen W C; Scheltens P
Anterior medial temporal lobe activation during attempted retrieval of encoded visuospatial scenes: an event-related fMRI study.
NeuroImage 2001;14(1 Pt 1):67-76.
2001: Barkhof F; van Waesberghe J H; Filippi M; Yousry T; Miller D H; Hahn D; Thompson A J; Kappos L; Brex P; Pozzilli C; Polman C H;
T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment.
Brain : a journal of neurology 2001;124(Pt 7):1396-402.
2001: Sormani M P; Miller D H; Comi G; Barkhof F; Rovaris M; Bruzzi P; Filippi M
Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets.
Journal of neurology, neurosurgery, and psychiatry 2001;70(4):494-9.
2001: Kalkers N F; Hintzen R Q; van Waesberghe J H; Lazeron R H; van Schijndel R A; Adèr H J; Polman C H; Barkhof F
Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy.
Journal of the neurological sciences 2001;184(2):155-62.
2001: Neele S J; Rombouts S A; Bierlaagh M A; Barkhof F; Scheltens P; Netelenbos J C
Raloxifene affects brain activation patterns in postmenopausal women during visual encoding.
The Journal of clinical endocrinology and metabolism 2001;86(3):1422-4.
2001: van Walderveen M A; Lycklama A Nijeholt G J; Adèr H J; Jongen P J; Polman C H; Castelijns J A; Barkhof F
Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
Archives of neurology 2001;58(1):76-81.
2001: Kalkers N F; Bergers L; de Groot V; Lazeron R H; van Walderveen M A; Uitdehaag B M; Polman C H; Barkhof F
Concurrent validity of the MS Functional Composite using MRI as a biological disease marker.
Neurology 2001;56(2):215-9.
2001: Nijeholt G J; Bergers E; Kamphorst W; Bot J; Nicolay K; Castelijns J A; van Waesberghe J H; Ravid R; Polman C H; Barkhof F
Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype.
Brain : a journal of neurology 2001;124(Pt 1):154-66.
2000: Barkhof F; Verrips A; Wesseling P; van Der Knaap M S; van Engelen B G; Gabreëls F J; Keyser A; Wevers R A; Valk J
Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings.
Radiology 2000;217(3):869-76.
2000: Barkhof F; Karas G B; van Walderveen M A
T1 hypointensities and axonal loss.
Neuroimaging clinics of North America 2000;10(4):739-52 ,ix.
2000: van Ouwerkerk W J; van der Sluijs J A; Nollet F; Barkhof F; Slooff A C
Management of obstetric brachial plexus lesions: state of the art and future developments.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2000;16(10-11):638-44.
2000: Rombouts S A; Barkhof F; Veltman D J; Machielsen W C; Witter M P; Bierlaagh M A; Lazeron R H; Valk J; Scheltens P
Functional MR imaging in Alzheimer's disease during memory encoding.
AJNR. American journal of neuroradiology 2000;21(10):1869-75.
2000: Molyneux P D; Kappos L; Polman C; Pozzilli C; Barkhof F; Filippi M; Yousry T; Hahn D; Wagner K; Ghazi M; Beckmann K; Dahlke F; Losseff N; Barker G J; Thompson A J; Miller D H
The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.
Brain : a journal of neurology 2000;123 ( Pt 11)():2256-63.
2000: Lazeron R H; Rombouts S A; Machielsen W C; Scheltens P; Witter M P; Uylings H B; Barkhof F
Visualizing brain activation during planning: the tower of London test adapted for functional MR imaging.
AJNR. American journal of neuroradiology 2000;21(8):1407-14.
2000: Lazeron R H; Langdon D W; Filippi M; van Waesberghe J H; Stevenson V L; Boringa J B; Origgi D; Thompson A J; Falautano M; Polman C H; Barkhof F
Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR.
Multiple sclerosis (Houndmills, Basingstoke, England) 2000;6(4):280-5.
2000: Molyneux P D; Brex P A; Fogg C; Lewis S; Middleditch C; Barkhof F; Sormani M P; Filippi M; Miller D H
The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2000;6(4):237-40.
2000: Tan I L; van Schijndel R A; Pouwels P J; van Walderveen M A; Reichenbach J R; Manoliu R A; Barkhof F
MR venography of multiple sclerosis.
AJNR. American journal of neuroradiology 2000;21(6):1039-42.
2000: Thompson A J; Montalban X; Barkhof F; Brochet B; Filippi M; Miller D H; Polman C H; Stevenson V L; McDonald W I
Diagnostic criteria for primary progressive multiple sclerosis: a position paper.
Annals of neurology 2000;47(6):831-5.
2000: Stevenson V L; Miller D H; Leary S M; Rovaris M; Barkhof F; Brochet B; Dousset V; Filippi M; Hintzen R; Montalban X; Polman C H; Rovira A; de Sa J; Thompson A J
One year follow up study of primary and transitional progressive multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2000;68(6):713-8.
2000: Rombouts S A; Barkhof F; Witter M P; Scheltens P
Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease.
Neuroscience letters 2000;285(3):231-3.
2000: Lycklama à Nijeholt G J; Castelijns J A; Lazeron R H; van Waesberghe J H; Polman C H; Uitdehaag B M; Barkhof F
Magnetization transfer ratio of the spinal cord in multiple sclerosis: relationship to atrophy and neurologic disability.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 2000;10(2):67-72.
2000: Tan I L; Lycklama à Nijeholt G J; Polman C H; Adèr H J; Barkhof F
Linomide in the treatment of multiple sclerosis: MRI results from prematurely terminated phase-III trials.
Multiple sclerosis (Houndmills, Basingstoke, England) 2000;6(2):99-104.
2000: Kalkers N F; de Groot V; Lazeron R H; Killestein J; Adèr H J; Barkhof F; Lankhorst G J; Polman C H
MS functional composite: relation to disease phenotype and disability strata.
Neurology 2000;54(6):1233-9.
2000: Machielsen W C; Rombouts S A; Barkhof F; Scheltens P; Witter M P
FMRI of visual encoding: reproducibility of activation.
Human brain mapping 2000;9(3):156-64.
2000: Molyneux P D; Miller D H; Filippi M; Yousry T; Kappos L; Gasperini C; Adèr H J; Barkhof F
The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion load measurement.
Journal of neurology 2000;247(1):34-40.
2000: Sie L T; Barkhof F; Lafeber H N; Valk J; van der Knaap M S
Value of fluid-attenuated inversion recovery sequences in early MRI of the brain in neonates with a perinatal hypoxic-ischemic encephalopathy.
European radiology 2000;10(10):1594-601.
2000: Witter M P; Naber P A; van Haeften T; Machielsen W C; Rombouts S A; Barkhof F; Scheltens P; Lopes da Silva F H
Cortico-hippocampal communication by way of parallel parahippocampal-subicular pathways.
Hippocampus 2000;10(4):398-410.
2000: Bot J C; Barkhof F; Lycklama à Nijeholt G J; Bergers E; Polman C H; Adèr H J; Castelijns J A
Comparison of a conventional cardiac-triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesions in multiple sclerosis.
European radiology 2000;10(5):753-8.
2000: Lycklama à Nijeholt G J; Uitdehaag B M; Bergers E; Castelijns J A; Polman C H; Barkhof F
Spinal cord magnetic resonance imaging in suspected multiple sclerosis.
European radiology 2000;10(2):368-76.
1999: van Waesberghe J H; Kamphorst W; De Groot C J; van Walderveen M A; Castelijns J A; Ravid R; Lycklama à Nijeholt G J; van der Valk P; Polman C H; Thompson A J; Barkhof F
Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.
Annals of neurology 1999;46(5):747-54.
1999: Rovaris M; Barkhof F; Bastianello S; Gasperini C; Tubridy N; Yousry T A; Sormani M P; Viti B; Miller D H; Filippi M
Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images.
Journal of neurology 1999;246(10):920-5.
1999: Sormani M P; Molyneux P D; Barkhof F; Miller D H; Filippi M
MRI enhancing lesion frequency from patients with MS enrolled in the placebo arms of clinical trials or in natural history studies.
Magnetic resonance imaging 1999;17(8):1236-7.
1999: Barkhof F
MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS).
Multiple sclerosis (Houndmills, Basingstoke, England) 1999;5(4):283-6.
1999: Verrips A; Nijeholt G J; Barkhof F; Van Engelen B G; Wesseling P; Luyten J A; Wevers R A; Stam J; Wokke J H; van den Heuvel L P; Keyser A; Gabreëls F J
Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis.
Brain : a journal of neurology 1999;122 ( Pt 8)():1589-95.
1999: van Walderveen M A; Barkhof F; Pouwels P J; van Schijndel R A; Polman C H; Castelijns J A
Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy.
Annals of neurology 1999;46(1):79-87.
1999: van Boxel-Dezaire A H; Hoff S C; van Oosten B W; Verweij C L; Dräger A M; Adèr H J; van Houwelingen J C; Barkhof F; Polman C H; Nagelkerken L
Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis.
Annals of neurology 1999;45(6):695-703.
1999: Barkhof F; Filippi M; van Waesberghe J H; Campi A; Miller D H; Adèr H J
Interobserver agreement for diagnostic MRI criteria in suspected multiple sclerosis.
Neuroradiology 1999;41(5):347-50.
1999: Sormani M P; Molyneux P D; Gasperini C; Barkhof F; Yousry T A; Miller D H; Filippi M
Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results.
Journal of neurology, neurosurgery, and psychiatry 1999;66(4):465-9.
1999: Berry I; Barker G J; Barkhof F; Campi A; Dousset V; Franconi J M; Gass A; Schreiber W; Miller D H; Tofts P S
A multicenter measurement of magnetization transfer ratio in normal white matter.
Journal of magnetic resonance imaging : JMRI 1999;9(3):441-6.
1999: van Walderveen M A; Truyen L; van Oosten B W; Castelijns J A; Lycklama à Nijeholt G J; van Waesberghe J H; Polman C; Barkhof F
Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity.
Archives of neurology 1999;56(3):345-51.
1999: Stevenson V L; Miller D H; Rovaris M; Barkhof F; Brochet B; Dousset V; Dousset V; Filippi M; Montalban X; Polman C H; Rovira A; de Sa J; Thompson A J
Primary and transitional progressive MS: a clinical and MRI cross-sectional study.
Neurology 1999;52(4):839-45.
1999: Verrips A; Wevers R A; Van Engelen B G; Keyser A; Wolthers B G; Barkhof F; Stalenhoef A; De Graaf R; Janssen-Zijlstra F; Van Spreeken A; Gabreëls F J
Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis.
Metabolism: clinical and experimental 1999;48(2):233-8.
1999: Rombouts S A; Scheltens P; Machielson W C; Barkhof F; Hoogenraad F G; Veltman D J; Valk J; Witter M P
Parametric fMRI analysis of visual encoding in the human medial temporal lobe.
Hippocampus 1999;9(6):637-43.
1999: van Waesberghe J H; Barkhof F
Magnetization transfer imaging of the spinal cord and the optic nerve in patients with multiple sclerosis.
Neurology 1999;53(5 Suppl 3):S46-8.
1998: van Waesberghe J H; van Buchem M A; Filippi M; Castelijns J A; Rocca M A; van der Boom R; Polman C H; Barkhof F
MR outcome parameters in multiple sclerosis: comparison of surface-based thresholding segmentation and magnetization transfer ratio histographic analysis in relation to disability (a preliminary note).
AJNR. American journal of neuroradiology 1998;19(10):1857-62.
1998: van Oosten B W; Truyen L; Barkhof F; Polman C H
Choosing drug therapy for multiple sclerosis. An update.
Drugs 1998;56(4):555-69.
1998: van Walderveen M A; Barkhof F; Tas M W; Polman C; Frequin S T; Hommes O R; Thompson A J; Valk J
Patterns of brain magnetic resonance abnormalities on T2-weighted spin echo images in clinical subgroups of multiple sclerosis: a large cross-sectional study.
European neurology 1998;40(2):91-8.
1998: Rombouts S A; Lazeron R H; Scheltens P; Uitdehaag B M; Sprenger M; Valk J; Barkhof F
Visual activation patterns in patients with optic neuritis: an fMRI pilot study.
Neurology 1998;50(6):1896-9.
1998: van Oosten B W; Barkhof F; Scholten P E; von Blomberg B M; Adèr H J; Polman C H
Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosis.
Archives of neurology 1998;55(6):793-8.
1998: van Waesberghe J H; Castelijns J A; Lazeron R H; Lycklama à Nijeholt G J; Barkhof F
Magnetization transfer contrast (MTC) and long repetition time spin-echo MR imaging in multiple sclerosis.
Magnetic resonance imaging 1998;16(4):351-8.
1998: Barkhof F; McGowan J C; van Waesberghe J H; Grossman R I
Hypointense multiple sclerosis lesions on T1-weighted spin echo magnetic resonance images: their contribution in understanding multiple sclerosis evolution.
Journal of neurology, neurosurgery, and psychiatry 1998;64 Suppl 1():S77-9.
1998: van Walderveen M A; Kamphorst W; Scheltens P; van Waesberghe J H; Ravid R; Valk J; Polman C H; Barkhof F
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis.
Neurology 1998;50(5):1282-8.
1998: Nijeholt G J; van Walderveen M A; Castelijns J A; van Waesberghe J H; Polman C; Scheltens P; Rosier P F; Jongen P J; Barkhof F
Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
Brain : a journal of neurology 1998;121 ( Pt 4)():687-97.
1998: van Waesberghe J H; van Walderveen M A; Castelijns J A; Scheltens P; Lycklama à Nijeholt G J; Polman C H; Barkhof F
Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR.
AJNR. American journal of neuroradiology 1998;19(4):675-83.
1998: Filippi M; Horsfield M A; Adèr H J; Barkhof F; Bruzzi P; Evans A; Frank J A; Grossman R I; McFarland H F; Molyneux P; Paty D W; Simon J; Tofts P S; Wolinsky J S; Miller D H
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis.
Annals of neurology 1998;43(4):499-506.
1998: Barkhof F J; Elton M; Lindeboom J; Tas M W; Schmidt W F; Hommes O R; Polman C H; Kok A; Valk J
Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study.
Journal of neurology 1998;245(3):153-8.
1998: Molyneux P D; Filippi M; Barkhof F; Gasperini C; Yousry T A; Truyen L; Lai H M; Rocca M A; Moseley I F; Miller D H
Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.
Annals of neurology 1998;43(3):332-9.
1998: Tubridy N; Coles A J; Molyneux P; Compston D A; Barkhof F; Thompson A J; McDonald W I; Miller D H
Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features.
Brain : a journal of neurology 1998;121 ( Pt 2)():225-31.
1998: Lycklama à Nijeholt G J; Castelijns J A; Weerts J; Adèr H; van Waesberghe J H; Polman C; Barkhof F
Sagittal MR of multiple sclerosis in the spinal cord: fast versus conventional spin-echo imaging.
AJNR. American journal of neuroradiology 1998;19(2):355-60.
1998: Filippi M; Gawne-Cain M L; Gasperini C; vanWaesberghe J H; Grimaud J; Barkhof F; Sormani M P; Miller D H
Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis.
Neurology 1998;50(1):238-44.
1998: Tubridy N; Ader H J; Barkhof F; Thompson A J; Miller D H
Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups.
Journal of neurology, neurosurgery, and psychiatry 1998;64(1):50-5.
1998: Egeler-Peerdeman S M; Barkhof F; Walchenbach R; Valk J
Cine phase-contrast MR imaging in normal pressure hydrocephalus patients: relation to surgical outcome.
Acta neurochirurgica. Supplement 1998;71():340-2.
1998: Scheltens P; Erkinjunti T; Leys D; Wahlund L O; Inzitari D; del Ser T; Pasquier F; Barkhof F; Mäntylä R; Bowler J; Wallin A; Ghika J; Fazekas F; Pantoni L
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes.
European neurology 1998;39(2):80-9.
1998: Rombouts S A; Barkhof F; Hoogenraad F G; Sprenger M; Scheltens P
Within-subject reproducibility of visual activation patterns with functional magnetic resonance imaging using multislice echo planar imaging.
Magnetic resonance imaging 1998;16(2):105-13.
1997: Barkhof F; Filippi M; van Waesberghe J H; Molyneux P; Rovaris M; Lycklama à Nijeholt G; Tubridy N; Miller D H; Yousry T A; Radue E W; Adèr H J
Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis.
Neurology 1997;49(6):1682-8.
1997: Barkhof F; van Waesberghe J H; Uitdehaag B M; Polman C H
Ibuprofen does not suppress active multiple sclerosis lesions on gadolinium-enhanced MR images.
Annals of neurology 1997;42(6):982.
1997: Barkhof F; Filippi M; Miller D H; Scheltens P; Campi A; Polman C H; Comi G; Adèr H J; Losseff N; Valk J
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.
Brain : a journal of neurology 1997;120 ( Pt 11)():2059-69.
1997: Filippi M; Barkhof F; Bressi S; Yousry T A; Miller D H
Inter-rater variability in reporting enhancing lesions present on standard and triple dose gadolinium scans of patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1997;3(4):226-30.
1997: Rombouts S A; Barkhof F; Hoogenraad F G; Sprenger M; Valk J; Scheltens P
Test-retest analysis with functional MR of the activated area in the human visual cortex.
AJNR. American journal of neuroradiology 1997;18(7):1317-22.
1997: van Waesberghe J H; Castelijns J A; Roser W; Silver N; Yousry T; Lycklama à Nijeholt G J; Adèr H J; Uitdehaag B M; Radue E W; Polman C H; Kappos L; Miller D H; Barkhof F
Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions.
AJNR. American journal of neuroradiology 1997;18(7):1279-85.
1997: van Oosten B W; Uitdehaag B M; Barkhof F; Hartung H P; Wagstaff J; Polman C H
Interleukin-2 therapy does not exacerbate multiple sclerosis.
Neurology 1997;49(2):633-4.
1997: Filippi M; van Waesberghe J H; Horsfield M A; Bressi S; Gasperini C; Yousry T A; Gawne-Cain M L; Morrissey S P; Rocca M A; Barkhof F; Lycklama à Nijeholt G J; Bastianello S; Miller D H
Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials.
Neurology 1997;49(2):371-7.
1997: van Oosten B W; Lai M; Hodgkinson S; Barkhof F; Miller D H; Moseley I F; Thompson A J; Rudge P; McDougall A; McLeod J G; Adèr H J; Polman C H
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial.
Neurology 1997;49(2):351-7.
1997: Lycklama à Nijeholt G J; Barkhof F; Scheltens P; Castelijns J A; Adèr H; van Waesberghe J H; Polman C; Jongen S J; Valk J
MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability.
AJNR. American journal of neuroradiology 1997;18(6):1041-8.
1997: Barkhof F; Polman C
Oral or intravenous methylprednisolone for acute relapses of MS?
Lancet 1997;349(9056):893-4.
1997: Barkhof F; Filippi M; Miller D H; Tofts P; Kappos L; Thompson A J
Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials.
Journal of neurology 1997;244(2):76-84.
1997: Truyen L; Barkhof F; Tas M; Van Walderveen M A; Frequin S T; Hommes O R; Nauta J J; Polman C H; Valk J
Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials.
Multiple sclerosis (Houndmills, Basingstoke, England) 1997;2(6):283-90.
1997: Rombouts S A; Machielsen W C; Witter M P; Barkhof F; Lindeboom J; Scheltens P
Visual association encoding activates the medial temporal lobe: a functional magnetic resonance imaging study.
Hippocampus 1997;7(6):594-601.
1997: Barkhof F; Smeets M; van der Valk P; Tan K E; Hoogenraad F; Peeters J; Valk J
MR imaging in retinoblastoma.
European radiology 1997;7(5):726-31.
1997: van Waesberghe J H; Castelijns J A; Scheltens P; Truyen L; Lycklana A Nijeholt G J; Hoogenraad F G; Polman C H; Valk J; Barkhof F
Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions.
Magnetic resonance imaging 1997;15(2):155-62.
1997: Taphoorn M J; Potman R A; Barkhof F; Weerts J G; Valk J; Karim A B; Heimans J J
Quantitative computer-assisted analysis vs. visual estimation of MR imaging response of brain metastases to radiotherapy.
Magnetic resonance imaging 1997;15(1):99-106.
1997: Scheltens P; Pasquier F; Weerts J G; Barkhof F; Leys D
Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging.
European neurology 1997;37(2):95-9.
1996: Rombouts S A; Barkhof F; Sprenger M; Valk J; Scheltens P
The functional basis of ocular dominance: functional MRI (fMRI) findings.
Neuroscience letters 1996;221(1):1-4.
1996: van Oosten B W; Barkhof F; Truyen L; Boringa J B; Bertelsmann F W; von Blomberg B M; Woody J N; Hartung H P; Polman C H
Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.
Neurology 1996;47(6):1531-4.
1996: Truyen L; van Waesberghe J H; van Walderveen M A; van Oosten B W; Polman C H; Hommes O R; Adèr H J; Barkhof F
Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.
Neurology 1996;47(6):1469-76.
1996: Lycklama à Nijeholt G J; Barkhof F; Castelijns J A; van Waesberghe J H; Valk J; Jongen P J; Hommes O R
Comparison of two MR sequences for the detection of multiple sclerosis lesions in the spinal cord.
AJNR. American journal of neuroradiology 1996;17(8):1533-8.
1996: van Oosten B W; Lai M; Barkhof F; Miller D H; Moseley I F; Thompson A J; Hodgkinson S; Polman C H
A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1996;1(6):339-42.
1996: Hommes O R; Barkhof F; Jongen P J; Frequin S T
Methylprednisolone treatment in multiple sclerosis: effect of treatment, pharmacokinetics, future.
Multiple sclerosis (Houndmills, Basingstoke, England) 1996;1(6):327-8.
1996: Truyen L; Barkhof F; Frequin S T; Polman C H; Tobi H; Hommes O R; Valk J
Magnetic resonance imaging of epilepsy in multiple sclerosis: a case control study. Implications for treatment trials with 4-aminopyridine.
Multiple sclerosis (Houndmills, Basingstoke, England) 1996;1(4):213-7.
1996: Miller D H; Albert P S; Barkhof F; Francis G; Frank J A; Hodgkinson S; Lublin F D; Paty D W; Reingold S C; Simon J
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
Annals of neurology 1996;39(1):6-16.
1996: van Waesberghe J H; Castelijns J A; Weerts J G; Nijeholt G J; Hillegers J P; Polman C H; Barkhof F
Disappearance of multiple sclerosis lesions with severely prolonged T1 on images obtained by a FLAIR pulse sequence.
Magnetic resonance imaging 1996;14(2):209-13.
1995: Filippi M; Horsfield M A; Tofts P S; Barkhof F; Thompson A J; Miller D H
Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis.
Brain : a journal of neurology 1995;118 ( Pt 6)():1601-12.
1995: Scheltens P; Launer L J; Barkhof F; Weinstein H C; van Gool W A
Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability.
Journal of neurology 1995;242(9):557-60.
1995: van Walderveen M A; Barkhof F; Hommes O R; Polman C H; Tobi H; Frequin S T; Valk J
Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images.
Neurology 1995;45(9):1684-90.
1995: Scheltens P; Barkhof F; Leys D; Wolters E C; Ravid R; Kamphorst W
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging.
Neurology 1995;45(5):883-8.
1995: Launer L J; Scheltens P; Lindeboom J; Barkhof F; Weinstein H C; Jonker C
Medial temporal lobe atrophy in an open population of very old persons: cognitive, brain atrophy, and sociomedical correlates.
Neurology 1995;45(4):747-52.
1995: Filippi M; Paty D W; Kappos L; Barkhof F; Compston D A; Thompson A J; Zhao G J; Wiles C M; McDonald W I; Miller D H
Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study.
Neurology 1995;45(2):255-60.
1995: van Oosten B W; Truyen L; Barkhof F; Polman C H
Multiple sclerosis therapy. A practical guide.
Drugs 1995;49(2):200-12.
1995: Baratti C; Barkhof F; Hoogenraad F; Valk J
Partially saturated fluid attenuated inversion recovery (FLAIR) sequences in multiple sclerosis: comparison with fully relaxed FLAIR and conventional spin-echo.
Magnetic resonance imaging 1995;13(4):513-21.
1994: Frequin S T; Lamers K J; Barkhof F; Borm G F; Hommes O R
Follow-up study of MS patients treated with high-dose intravenous methylprednisolone.
Acta neurologica Scandinavica 1994;90(2):105-10.
1994: Barkhof F; Tas M W; Frequin S T; Scheltens P; Hommes O R; Nauta J J; Valk J
Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis.
Neuroradiology 1994;36(5):382-7.
1994: Barkhof F; Kouwenhoven M; Scheltens P; Sprenger M; Algra P; Valk J
Phase-contrast cine MR imaging of normal aqueductal CSF flow. Effect of aging and relation to CSF void on modulus MR.
Acta radiologica (Stockholm, Sweden : 1987) 1994;35(2):123-30.
1994: van Walderveen M A; Tas M W; Barkhof F; Polman C H; Frequin S T; Hommes O R; Valk J
Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis.
Neurology 1994;44(2):327-9.
1994: Zijlstra E J; Taphoorn M J; Barkhof F; Hoogenraad F G; Heimans J J; Valk J
Radiotherapy response of cerebral metastases quantified by serial MR imaging.
Journal of neuro-oncology 1994;21(2):171-6.
1993: Miller D H; Barkhof F; Nauta J J
Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis.
Brain : a journal of neurology 1993;116 ( Pt 5)():1077-94.
1993: Frequin S T; Lamers K J; Borm G F; Barkhof F; Jongen P J; Hommes O R
T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
Acta neurologica Scandinavica 1993;88(2):80-6.
1993: Frequin S T; Wevers R A; Braam M; Barkhof F; Hommes O R
Decreased vitamin B12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after high-dose intravenous methylprednisolone.
Journal of neurology 1993;240(5):305-8.
1993: Barkhof F; Thompson A J; Kappos L; Nauta J J; Yousri T; Berry I; Scotti G; Appel B; Tofts P S; Miller D H
Database for serial magnetic resonance imaging in multiple sclerosis.
Neuroradiology 1993;35(5):362-6.
1992: Barkhof F; Scheltens P; Frequin S T; Nauta J J; Tas M W; Valk J; Hommes O R
Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
AJR. American journal of roentgenology 1992;159(5):1041-7.
1992: Frequin S T; Barkhof F; Lamers K J; Hommes O R
The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis.
Journal of neuroimmunology 1992;40(2-3):265-72.
1992: Frequin S T; Barkhof F; Lamers K J; Hommes O R; Borm G F
CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.
Acta neurologica Scandinavica 1992;86(3):291-7.
1992: Barkhof F; Valk J; Hommes O R; Scheltens P; Nauta J J
Gadopentetate dimeglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T.
AJNR. American journal of neuroradiology 1992;13(4):1257-9.
1992: Scheltens P; Barkhof F; Valk J; Algra P R; van der Hoop R G; Nauta J; Wolters E C
White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity.
Brain : a journal of neurology 1992;115 ( Pt 3)():735-48.
1992: Barkhof F; Valk J; Hommes O R; Scheltens P
Meningeal Gd-DTPA enhancement in multiple sclerosis.
AJNR. American journal of neuroradiology 1992;13(1):397-400.
1992: Barkhof F; Frequin S T; Hommes O R; Lamers K; Scheltens P; van Geel W J; Valk J
A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
Neurology 1992;42(1):63-7.
1991: Miller D H; Barkhof F; Berry I; Kappos L; Scotti G; Thompson A J
Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.
Journal of neurology, neurosurgery, and psychiatry 1991;54(8):683-8.
1991: Barkhof F; Hommes O R; Scheltens P; Valk J
Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis.
Neurology 1991;41(8):1219-22.
1991: Barkhof F; Scheltens P; Valk J; Waalewijn C; Uitdehaag B M; Polman C H
Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using Gadolinium- "enhanced" STIR imaging.
Neuroradiology 1991;33(1):70-1.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Frederik Barkhof

Research Profile (preview)

Concepts & Ideas

Disorders

Anatomy

Physiology

Procedures

Activities & Behaviors

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Frederik Barkhof (preview)

All Publications